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ABSTRACT
Bisphenol A (BPA) exposure has recently become a public health
concern, and the safety of the utilization of BPA has attracted the attention of the
scientific community, politicians, and the general population. Although BPA is
banned from baby products in a few countries because infants and young
children are particularly susceptible to endocrine disruption, recent studies have
consistently indicated the association between urinary BPA concentration and
cardiovascular diseases in adults. Therefore, adult exposure to this xenoestrogen
is becoming a healthcare issue that cannot be ignored. We selected large
conductance Ca2+/voltage sensitive potassium (BK) channels as one of the target
proteins for BPA effects because the function and expression of BK channels are
regulated by estrogen. Additionally, BK channels play an important role in
vascular function and changes in BK expression are associated with disease. We
hypothesized that BPA would differently affect BK channel function and
expression via separate non-genomic and genomic mechanisms. The goals of
our studies were 1) to characterize a novel, membrane-permeable, and
economical antagonist called penitrem A to facilitate the study of BK channels, 2)
to determine the mechanisms by which BPA increases BK channel activity and,
3) to determine the mechanisms by which BPA reduces vascular BK channel
expression.
Current from patches of HEK 293 cells transfected with hSlo α or α + β1
were blocked >95% by penitrem A (IC50 6.4 vs. 64.4 nM; p<0.05). Further,
penitrem A inhibited BK channels in inside-out and cell-attached patches,

whereas iberiotoxin could not. Inhibitory effects of penitrem A on whole-cell K+
currents were equivalent to iberiotoxin in canine coronary smooth muscle cells.
Penitrem A enhanced sensitivity to K+-induced contraction in canine coronary
arteries by 23 ± 5% (p<0.05) and increased the blood pressure response to
phenylephrine in anesthetized mice by 36 ± 11% (p<0.05).
In cultured canine coronary artery smooth muscle cells (CASMC), acute
BPA (10 µM) exposure increased BK channel currents 179 ± 8% (p<0.05).
Inside out recordings from native canine CASMCs showed that acute BPA
increased BK channel open probability (Po) from 0.11 ± 0.03 to 0.47 ± 0.09 at
+40 mV (p<0.05). HEK cells transfected with BK α subunits alone were
insensitive to acute BPA (currents at +100 mV were 101 ± 13% of control) while
acute BPA increased BK channel currents by 53 ± 12% (p<0.05) when cells were
transfected with α and β1 subunits. Similarly, single channel recordings indicated
NPo was 123 ± 20% of control in the BK α subunits alone with BPA, however,
acute BPA increased NPo 201 ± 41% in patches from cells expressing BK α and
β1 subunits. Thus, BK β1 subunits facilitated BPA-induced BK channel activation
and the effects of BPA were non-genomic, as these effects were observed in
cell-free patches.
In contrast to the acute effects of BPA on BK channel activity, 48-72 hrs of
BPA (10 µM) exposure decreased BK channel expression in A7r5 cells and
cultured rat aorta. Western blot data indicated that BK α subunit protein content
was 33 ± 8% of control in BPA-treated aorta (p<0.05). Patch clamp recording
showed that whole cell current densities at +100 mV were 57 ± 7% lower in aortic

SMC treated with 10 µM BPA (p<0.05) while whole cell current densities from
aortic SMC treated with BPA + ICI 182780 (100 nM; an estrogen receptor
blocker) were not different (101 ± 14% of control). Penitrem A-sensitive current
densities at 100 mV were 53.9 ± 14.8, 12.0 ± 3.0, and 48.4 ± 10.1 pA/pF in
DMSO, BPA and BPA + ICI 182780, respectively (p<0.05). Thus, chronic BPA
exposure decreased BK channel expression by estrogen receptor mediated
signaling.
Our data indicate: 1) penitrem A is an economical alternative to iberiotoxin
for BK channel analysis; 2) acute BPA exposure activates BK channel activity
and BK β1 subunits play a role in BPA induced BK channel activation; 3) chronic
BPA exposure decreases vascular BK channel expression via estrogen receptordependent mechanisms. Although acute BPA exposure activates the BK channel
through a non-genomic mechanism that could be beneficial for heart due to
coronary dilation, longer BPA exposure decreases the number of functional BK
channels through a genomic mechanism that could be detrimental to the heart.
Thus, the overall effect of BPA exposure on vascular function may be harmful
due to disruption of BK channel-mediated vascular regulation. Taken together,
these results indicated BPA induced altered BK channel function and expression
may be one of the mechanisms for the association between BPA exposure levels
and cardiovascular diseases seen in epidemiological studies.
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SPECIFIC AIMS
Scientific and technological advances provide a variety of chemicals for
tremendous benefit; however, concerns have been raised regarding
environmental exposure to xenoestrogens that disrupt endocrine function.
Recent data suggest that the effect of estrogen on cardiovascular physiology is
far more complicated than previously envisioned. Because we do not fully
understand the function of estrogen in cardiovascular health and disease, it is
difficult to predict the effects of xenoestrogens and endocrine disruptors on
cardiovascular physiology. One estrogenic endocrine disruptor, bisphenol A
(BPA), holds enormous financial and practical importance for plastic
manufacturers, but issues surrounding its safety create concern. A recent
epidemiological study associated urinary BPA levels with cardiovascular
diseases including angina, atherosclerosis, and myocardial infarction(Lang et al.,
2008). Mechanistic data regarding effects of BPA on the cardiovascular system
are scarce; therefore, we do not yet understand how BPA could be linked to
coronary heart conditions. BPA acts on nuclear estrogen receptors (ER) to
mediate genomic effects, while non-genomic effects of BPA appear to originate
at the cell membrane. Membrane targets for BPA remain unclear, but include the
G protein-coupled estrogen receptor (GPER30; (Thomas & Dong, 2006)) and ion
channels (Choi et al., 2007). Importantly, there are no data available regarding
the effect of BPA on the function and expression of ion channels in vascular
smooth muscle cells (VSMC), a cell type involved intimately in angina,
atherosclerosis, and myocardial infarction.

xi

Large conductance Ca2+/voltage-sensitive K+ (BK) channel is an excellent
model for studying non-genomic effects of BPA, because its activity is estrogensensitive (Valverde et al., 1999; Dick & Sanders, 2001). The BK channel is also
an excellent model for studying genomic actions of BPA, because the underlying
gene, KCNMA1, is regulated by estrogen (Kundu et al., 2007). BK channels are
highly expressed in VSMC, possess the regulatory β1 subunit (Tanaka et al.,
1997), and regulate coronary vascular tone (Ledoux et al., 2006; Borbouse et al.,
2009). Our long-range goal is to identify molecular mechanisms by which
estrogenic chemicals affect vascular function. Our objective in this application is
to determine mechanisms by which BPA modulates BK channel expression and
function. The central hypothesis is that BPA alters BK channel expression and
function through separate genomic and non-genomic mechanisms. The rationale
is that receptors for BPA exist at both the cell membrane and in the nucleus. To
test the central hypothesis and achieve the objective, we propose 2 specific
aims:

1. Determine the non-genomic mechanism by which BPA increases BK
channel activity in VSMC. The working hypothesis is that BPA increases BK
channel activity by binding to an extracellular site on the channel that is
comprised, at least in part, of the regulatory β1 subunit. Patch clamp studies will
be performed on VSMC using a derivative of BPA that we have synthesized.
BPA-monosulfate (BPA-MS) is permanently charged, membrane-impermeable,
and will be used to determine on which side of the membrane the binding site

xii

resides. The role of the β1 subunit will be determined using cloned BK channels
composed of α or α + β1 subunits.

2. Determine the genomic mechanism by which BPA decreases BK channel
expression in VSMC. The working hypothesis is that BPA reduces BK channel
expression by activating nuclear ER. Western blots will be used to determine the
expression level of BK channels in VSMC treated with BPA. The pure ER
antagonist Fulvestrant (ICI 182,780) and BPA-MS will be used to determine the
involvement of nuclear and membrane ER in BPA-induced reductions of BK
channel protein expression.

We expect, at the completion of this project, to define mechanisms by which BPA
increases BK channel activity and reduces BK channel expression in VSMC.
Knowing the mechanisms of action of BPA on VSMC will aid interpretation of
correlative studies regarding BPA exposure and human health. The proposed
work is innovative because it addresses both genomic and non-genomic effects
of BPA related to ion channels, VSMC, and cardiovascular disease.
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CHAPTER 1 Background and significance
Overview of BPA
BPA exposure and health concerns
BPA is used to manufacture products including polycarbonate plastic, the
resin inside of cans, dental sealants, and as a non-polymer additive to other
plastics. Since BPA is a versatile material, over 6 billion pounds are produced
each year, and over 100 tons are disposed of on the earth (Vandenberg et al.,
2009). BPA, which possesses estrogen mimetic properties, has recently become
the subject of much interest and attention. BPA is public health concern due to
exposure in the environment, and a possible association with several
pathological conditions. According to the National Health and Nutrition
Examination Survey (NHANES) conducted during 1988-1994, BPA was detected
in over 95 % of population (Calafat et al., 2005). Newer data collected during
2003-2004 also supports the initial finding of widespread human BPA exposure
(Calafat et al., 2008). Notably, the geometric mean of BPA exposure from 20032004 NHANES (2.6 µg/L) was twice as large as the one from 1988-1994 (1.33
µg/L). These data may suggest that BPA exposure is continuously increasing
over the years.
Currently, the U.S. Food and Drug Administration (FDA) and the U.S.
Environmental Protection Agency (EPA) state the reference dose; a daily
exposure to the human population that is likely to be without an appreciable risk
of deleterious effect during a lifetime, of BPA is 50 µg kg-1 day-1. Importantly,
there is continuing controversy whether this current acceptable daily intake level
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is an appropriate estimate for the safe level. A number of recent studies are
suggesting the possible low dose effect of BPA, which may involve totally newly
mechanisms that alter cellular functions. Furthermore, many studies have
detected BPA in urine, blood and tissue; however, the levels of BPA exposure
are controversial. BPA has been shown to accumulate in adipose tissue (Nunez
et al., 2001; Fernandez et al., 2007) so that the local BPA concentration in tissue
could be higher than the values reported in total blood BPA concentration.
Furthermore, cumulative BPA exposure levels may play a role in BPA associated
pathologies. Additionally, this reference dose was calculated based on a
toxicological experiment to determine the lowest observed adverse effect level
(LOAEL) in the 1980’s. Thus, there is a desperate need for updated data
regarding BPA’s toxicological aspects.
Although there is no clear consensus of adverse health effects from BPA,
the large body of evidence suggested that BPA possesses endocrine disrupting
activities in a tissue specific manner. Specifically, BPA may be associated with
altered fetal/neonatal development (Vandenberg et al., 2007), reproductive
function (Savabieasfahani et al., 2006), metabolic homeostasis (Hugo et al.,
2008) and carcinogenesis (Wetherill et al., 2002; Wetherill et al., 2005). Thus, the
U.S. Food and Drug Administration (FDA) and National Toxicology Program
(NTP) at the National Institute of Health state that they have “ some concerns
regarding the potential effect of BPA on the brain, behavior, and the prostate
gland in fetuses, infants and young children
(http://www.fda.gov/newsevents/publichealthfocus/ucm064437.htm).
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Toxicodynamics / toxicokinetics of BPA
BPA is a lipophilic molecule that contains 2 phenol rings, which resembles other
toxic chemicals such as diethylstilbestrol (DES) and
dichlorodiphenyltrichloroethane (DDT) (Fig. 1-1). These compounds were
banned due to their endocrine disrupting properties and have been associated
with an increased risk of tumor development (Vandenberg et al., 2009). Similarly,
one of the well-known chemical properties of BPA is an estrogenic property that
interacts with estrogen receptors (ERs) to activate estrogen signals.
Conventionally, it is known that endocrine disrupters act via nuclear estrogen
receptors as 17 β-E2 acts on ERs, however, the mechanisms of non-genomic
effects such as the involvement of membrane receptors or ion channels are not
well established. Indeed, xenoestrogens were reported to be much less potent
than 17 β-E2 (Krishnan et al., 1993; Kuiper et al., 1997). Recent studies have
demonstrated that the nongenomic action of BPA may be associated with altered
intracellular Ca2+ homeostasis (Nadal et al., 2000; Alonso-Magdalena et al.,
2005; Walsh et al., 2005). Yet, the exact mechanisms of BPA induced alterations
remain unknown. Given that BPA has a low affinity for binding with classical
nuclear receptors; it is possible that non-genomic effects of BPA may play an
important role in BPA associated altered cellular function in addition to classical
genomic ER signaling disruption.
In terms of BPA toxicokinetics, studies have been shown that the half-life
of BPA in the blood range from 4 to 6 hours in humans (Volkel et al., 2002; Volkel
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et al., 2005). Considering the studies demonstrating that the half life of BPA in
the blood is a relatively short time, and the studies showing the detection of BPA
from urine samples in over 90% of population (Calafat et al., 2005; Calafat et al.,
2008), the environmental BPA exposure to humans must be continuous.
Alternatively, it is possible that BPA can be stored in the body and constantly
released into the blood. Indeed, toxicological studies have shown that BPA
accumulates in brown adipose tissue in rats (Nunez et al., 2001) and BPA and its
derivatives were detected in the adipose tissue of women (Fernandez et al.,
2007). Since there are no doubts about the prevalence of BPA in our body,
further research is needed to explore the pharmacokinetic/dynamics of BPA and
how it is related to the BPA associated pathologies seen in epidemiological
studies.

4

Figure 1 1 Chemical structures of E2 and xenoestrogens and related
compounds.
Structures of 17β-estradiol and endocrine disruptors are shown. The structure of
BPA is very similar to Dichlorodiphenylene (DDE) and Diethylstilbestrol (DES).
DDE is a metabolite of DDT, which was banned as a pesticide due to its
carcinogenic properties. DES is a pharmaceutical estrogen that was also banned
(Watson et al., 2007)
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Figure 1 2 Chemical reactions to release BPA from polycarbonate products.
BPA molecule is released from polycarbonate products by the hydrolysis of the
ester bond. The chemical reaction is facilitated during certain conditions,
including high temperatures and acidic or basic environments. (Welshons et al.,
2006)
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Sources of BPA
Although BPA has been detected in a variety of sources including food,
beverages, air, soil, and house dust, the major BPA exposure source was
considered through dietary ingestion (Miyamoto & Kotake, 2006; Wilson et al.,
2007). Particularly, BPA has been shown to leach from polycarbonate
compounds such as plastic containers and canned food. The initial report of BPA
being released was in an accidental experiment showing that an estrogenic
substance was suspected of leaching from autoclaving solution in polycarbonate
flasks (Krishnan et al., 1993). As in all general chemical reactions, hydrolysis of
ester bonds in polycarbonate products is facilitated at high temperature and pH
levels (Fig. 1-2). Examples commonly seen in our lives may be washing a plastic
container with harsh detergent, or heating it, or storing acidic/basic food in it.
Indeed some of these conditions are shown to release BPA (Brotons et al., 1995;
Kang et al., 2003).
Interestingly, a recent study reported that the BPA levels did not decline
with fasting conditions in human subjects (Stahlhut et al., 2009). This study may
suggest that the oral route may not be the only route of BPA exposure.
Additionally, BPA has been shown to be stored in adipose tissue (Nunez et al.,
2001; Fernandez et al., 2007), therefore, cumulative BPA levels may also need
to be considered when the source of BPA exposure needs to be determined.
Taken together, there are no doubts about human BPA exposure; however, the
exact source of BPA is not known. It is likely to be multiple sources responsible
for human BPA exposure.
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BPA and cardiovascular diseases
In 2008, an initial epidemiological study demonstrated a significant
relationship between urinary BPA concentration and cardiovascular diseases in
the general adult population from the United States (Lang et al., 2008a). This
cross-sectional analysis utilized data from the National Health and Nutrition
Examination Survey 2003-2004 and the data indicated higher BPA
concentrations were associated with cardiovascular diagnosis, diabetes, and
altered liver enzyme levels. Later, newer data from the NHANES 2005-2006 also
appeared consistent with an association between urinary BPA concentration and
cardiovascular disease (Melzer et al., 2010). Additionally, high levels of BPA in
serum were associated with atherosclerotic plaques in the aged population (Lind
& Lind, 2011). Occupational levels of BPA exposure also have been associated
with an increased risk of male sexual dysfunctions such as erectile dysfunction
(Li et al., 2010). Although government agencies have concerns due to BPA’s
potential harmful effects on fetuses, infants and young children, these studies
may suggest that BPA toxicity is not limited to the specific population but rather,
a global effect to all populations.
All taken together, BPA has become a public health concern only in the
last few years, and many controversies exist about routes of exposure, the
quantity we are exposed to, mechanisms of BPA action, and its associations with
diseases (Vandenberg et al., 2009). Since constant BPA exposures are
suspected and therefore this phenomenon will continue to intensify, early and
conclusive studies for safety are extremely important to prevent public health
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hazards like the ones that have been created by the use of materials such as
asbestos and dichlorodiphenyltrichloroethane (DDT).

Overview of ion channels in VSM
Ion channel and toxicological compounds
Ion channels are macromolecular protein complexes that form pores in
cell membranes, which regulate the movement of ions. The membrane potential
determined by these ion channels are critical, since excitable cells utilize
electricity for communication between the extracellular side and intracellular side
to further propagate intracellular signal transduction to trigger a cellular response.
(i.e. Ca2+ flux). Thus, ion channels located in the membrane make very
convenient targets for altering cellular function. As shown in nature, many toxins
(i.e. tetrodotoxin, iberiotoxin, charybdotoxin) are designed to alter ion channel
functions, and are used as predators’ weapons to establish a dominant world
where the strong prey upon the weak. Furthermore, the disruption of membrane
integrity by forming transmembrane pores (gramicidin, amphotericin, nystatin,) is
also a great example of how important the ion channel is in the membrane to
regulate ionic gradients between extracellular and intracellular spaces. In other
words, ion channels may be susceptible to toxicological chemicals.

Potassium channels in VSMC
The primary function of VSMC is contraction, as in other muscle types
such as skeletal and cardiac muscle. Calcium dependent muscle contraction
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obeys the basic principle of excitation-contraction coupling (ECC) which explains
the membrane excitability and intracellular Ca2+ concentration that regulates
muscle contraction. As in other muscles, the two key players in ECC are voltage
dependent L-type Ca2+ channel (Cav1.2) and ryanodine receptor (RYR) in the
VSMC. Similar to other muscles, voltage dependent L-type Ca2+ channels are
activated by membrane depolarization resulting in Ca2+ flux through extracellular
component to increase global intracellular Ca2+ concentration (Moosmang et al.,
2003). Therefore, ion channels contributing to the dynamic regulation membrane
potential (Em) are key factors for VSMC contraction (Nelson et al., 1990).
Particularly, K+ channels are important molecules in negative feedback
mechanisms to set the resting membrane potential since the equilibrium potential
of K+ are more negative than the resting membrane potential. Multiple types of K+
channels are identified in VSMC: 1) Inward rectifying K channel (Kir), 2) ATP
sensitive K+ channel (KATP) 3) Voltage dependent K+ channels (KV), and 4):
Calcium dependent K+ channels (KCa) (Holdefer et al., 1976; Nelson & Brayden,
1993; Quayle et al., 1997; Dick & Tune, 2010). These potassium channels in
VSMC, that provide hyperpolarizing currents, play a critical role in maintaining
the resting membrane potential, and each type of K+ channel has its own unique
biophysical properties.

Kir and KATP channels
Both Kir and KATP channels are categorized in the same phylogenetic tree
and have been shown to express in vascular smooth muscle (Kubo et al., 2005).
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The structure of the Kir family is composed of 2 transmembrane domains termed
M1 and M2 with pore forming H5 regions that serves as ion selectivity filters
(Bichet et al., 2003). Functional properties of Kir currents in VSMC were
characterized by patch clamp recording (Edwards & Hirst, 1988; Edwards et al.,
1988). Patch clamp recordings demonstrated strong inward rectifying barium
sensitive currents and increasing extracellular [K+] increased the conductance. In
terms of the physiological role of Kir channels in VSM, moderate increases in the
extracellular [K+] (3-20 mM) have been shown to cause vasodilation through a
mechanism depending on Kir channel activation in cerebral arteriole (Girouard et
al., 2010). In VSMC, Kir2.1 transcript was detected, but not Kir2.2 and Kir2.3 from
rat cerebral, coronary and mesenteric arteries (Bradley et al., 1999). To support
this gene expression data further, functional data also indicated that the cerebral
artery from Kir2.2 KO mice responds to extracellular K+, but not the cerebral
artery from Kir2.1 KO mice (Zaritsky et al., 2000). Thus, this molecular and
functional evidence suggests that vascular Kir channels are composed of Kir2.1.
On the other hand, KATP channels are composed of Kir6.1 and Kir6.2 with
unique subunits known as sulfonylurea receptors (SUR). As in the Kir2.1 subunit,
Kir6.1 and Kir6.2 subunits are composed of 2 transmembrane domains, M1 and
M2, without voltage sensor domain such as S4 segment, thus KATP channel
currents are not voltage dependent. Nonetheless, SUR subunits serve as the
intracellular ATP binding site to regulate KATP channel. Although human coronary
endothelial KATP channel has been shown to express as a heteromeric complex
of Kir6.1, Kir6.2 and SUR2B, it was not demonstrated in human coronary artery
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smooth muscle cells (Yoshida et al., 2004). Indeed, human coronary artery
smooth muscle cells expressed Kir6.1, Kir6.2 and SUR2B mRNAs, however, a
heteromeric complex of Kir6.1 and Kir6.2 was not confirmed as in the human
coronary endothelial cells. In contrast, another study showed only Kir6.1 and
SUR2B mRNA expression (Miura et al., 2003). These molecular biological data
are further supported by the functional data that demonstrate that the aortic
vascular responses to KATP channel agonists/antagonist (pinacidil, diazoxide and
glibenclamide) are not different between wild type and Kir6.2 KO mice (Suzuki et
al., 2001). Thus, this molecular and functional evidence suggests that the
vascular KATP channel is composed of Kir6.1 and SUR2B. In terms of the
physiological role of KATP channel in VSM, it has been suggested that KATP
channel plays an important role in ischemic vasodilation (Dart & Standen, 1995).
This is because the SUR regulatory subunits serve as the sensor for intracellular
ATP levels and the KATP channel is generally inhibited due to sufficient levels of
ATP under normal physiological conditions. KATP channel is also activated by the
G-protein mediated cAMP dependent protein kinase (PKA) (Standen & Quayle,
1998). For instance, adenosine induced vasodilation involves adenylyl cyclasecAMP-PKA pathways to activate KATP channel.

KV channels
KV channels are one of the most diverse potassium channels. Although
they are classified into KV1- KV12 subfamilies and each subfamily contains
several isoforms, the expression of KV1, KV2, KV3, KV4, KV7 and KV9 channel
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subfamilies have been confirmed in vascular smooth muscle. (Gutman et al.,
2003; Wulff et al., 2009). KV channel is composed of pore forming alpha subunits
that can be homotetramers or heterotetramers of different families. The α subunit
contains 6 transmembrane domains and the S4 segment serves as a voltage
sensor. The S5-S6 linker and P-loop form the outer funnel and pore in KV
channels. The K+ selective filter allows K+ ions go through the pore using the
highly selective dehydration of K+ ions (MacKinnon, 2003). In addition, KV
channels have been suggested to contain auxiliary β subunits that can regulate
the channel function. Although the exact molecular composition of KV channel is
not clear because the composition of KV channels seem to be different
depending on the vascular beds, KV channels are likely to be composed of
heteromultimeric KV α subunits with diversity of β subunits that enables the
formation of a variety of KV channels to response to appropriate physiological
demand in the vessels (i.e. conduit vs resistance). For instance, KV α subunits
(KV1.1, KV1.2, KV1.4, KV1.5, KV1.6, KV2.1 and KV9.3) are expressed in rat
pulmonary arterial smooth muscle cells (Yuan et al., 1998), while KV α subunits
(KV1.1- KV1.8 except KV1.4) are expressed in canine coronary artery (Dick et al.,
2008). Interestingly, within the diverse family of KV genes, some KV genes are
particularly important in vascular function. Specifically, a mutant KV1.5 gene
overexpression caused endogenous functional KV channels to switch
dysfunctional KV channels due to the incorporation of mutant KV1.5 (Chen et al.,
2006). This dominant negative approach resulted in altered myogenic response
and membrane potential in the vessels.
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BK channel
Large conductance Ca2+/voltage- activated K+ (BK) channels are expressed in
variety of tissues and involved in variety of cellular process including circadian
rhythms (Meredith et al., 2006) vascular regulation (Nelson et al., 1995; Brenner
et al., 2000), hearing function (Pyott et al., 2007). BK channels are composed of
4 α subunits encoded by KNCMA1 gene with auxiliary β subunits encoded by
KCNMB1-4 genes. Although a single gene encodes the α subunit, it undergoes
alternative splicing processes to yield several splicing variants that have diverse
channel characteristics (Butler et al., 1993; Tseng-Crank et al., 1994). As a
schematic BK channel structures are shown in Fig. 1-3, the α subunit contains 7
transmembrane segments (S0 to S6) with N-terminus located at the extracellular
side and C-terminus located at the intracellular side. Similar to other voltage
sensitive K channel families, S4 segment serves as a voltage sensor to regulate
BK channel opening/closing states (Cui & Aldrich, 2000).
In addition to the voltage regulation, there are Ca2+ sensor sites similar to
EF hand motif located at cytoplasmic C-terminal tail side. Furthermore, currently,
there are 4 auxiliary β subunits encoded by KCNMB1-4 genes identified and
each β subunit provides further unique BK channel properties. Specifically, first β
subunits are isolated from smooth muscle membrane and identified as β1 subunit
(Knaus et al., 1994a). The role of the β1 subunit is allosteric regulations of BK
channel by improving the sensitivity to voltage and intracellular Ca2+ (Fig. 1-4)
(Carl & Sanders, 1989; Cox et al., 1997; Cox & Aldrich, 2000). Thus, BK channel
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β1 subunits have been suggested to play a key role in regulation of vascular tone
(Brenner et al., 2000) and urinary bladder function (Petkov et al., 2001). It also
regulates the functional surface expression of α subunits (Toro et al., 2006).
Furthermore, β1 subunit-dependent BK channel activation was reported with
steroid hormones (Valverde et al., 1999; Lovell et al., 2004; King et al., 2006;
Bukiya et al., 2007). β2 subunits are expressed inn adrenal gland and
hippocampal neuron and it uniquely causes inactivation of BK channel currents
(Solaro & Lingle, 1992; Hicks & Marrion, 1998; Wallner et al., 1999). The
expression of β3 subunit is confirmed in testis, pancreas and spleen and it
causes a rapid inactivating BK channel currents (Xia et al., 2000). β4 subunits
are primary expressed in brain and presence of β4 subunits make BK channel
insensitive to iberiotoxin (Meera et al., 2000). In summary, β subunits alter Ca2+,
voltage and chemical agonists/antagonists sensitivities.
The primary role of BK channel has been suggested to act as negative
feedback mechanism to regulate the opening of L-type voltage gated Ca2+
channels in vascular smooth muscle cells by voltage and intracellular Ca2+ levels
(Fig. 1-5). Ca2+ spark, local increase in subsarcolemmal Ca2+, is coupled with BK
channel activity, causing hyperpolarizing membrane potential to counter
vasoconstriction (Nelson et al., 1995). Although BK channel mediate relaxation of
arterial smooth muscle by Ca2+ sparks is evident in cerebral artery (Nelson et al.,
1995), recent data suggest the heterogeneity in the contribution of BK channels
in vasculature tone in vascular beds (Yang et al., 2009). Thus, the physiological
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role and the mechanism of BK channel activation may be far more complex and
important than previously envisioned.
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Figure 1 3 Molecular structure of BK channel α subunit and β1 subunit.
The schematic diagram shows the key amino acid residues involved in
modulation of BK channel. + indicates activation of BK channel and – indicates
inhibition of BK channel. (Hou et al., 2009)
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Figure 1 4 Dual regulation by Ca2+ and voltage on BK activity.
(A) BK channel activity is plotted against voltage and Ca2+ concentration. (B) G-V
relationship shifts toward the left as intracellular Ca2+ concentration increases
(Carl & Sanders, 1989)
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Figure 1 5 The function of BK channel in vascular smooth muscle cells.
Ca2+ spark activates BK channel and causes membrane hyperpolarization due to
K+ efflux. This membrane hyperpolarization blocks L-type Ca2+ channel to
decrease the global Ca2+ concentration levels in cytosol. BK channel regulates
intracellular Ca2+ levels using this negative feedback system. (Standen, 2000)
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BK channel and vascular pathologies
Aging, hypertensive and diabetic vascular BK channels
In vascular smooth muscle cell, local intracellular Ca2+ increase can
paradoxically induce smooth muscle relaxation. This is explained by the
activating of the vascular BK channel that results in membrane hyperpolarization
(Nelson et al., 1995). Therefore, BK channel has been recognized as one of the
key molecules for vascular tone in a variety of vessels. Indeed, alterations in BK
channel expression in vascular smooth muscle is associated with hypertension,
aging, and diabetic related altered vascular functions in variety of vascular beds
(Liu et al., 1997; Liu et al., 1998; Marijic et al., 2001; Lu et al., 2005; McGahon et
al., 2007; Lu et al., 2008; Borbouse et al., 2009)
Specifically, cerebral artery smooth muscle cells from genetically
hypertensive rats exhibited over 4-fold higher BK channel current density and BK
α subunits expression compared to Wistar-Kyoto rat cerebrovascular smooth
muscle cells (Liu et al., 1998). Similarly, hypertension-induced increased BK
channel has been demonstrated in aortic smooth muscle cells from
spontaneously hypertensive rats (Liu et al., 1997). Hypertension induced
increased BK channel expression is considered compensatory mechanism to
counteract the increased cerebral vascular tone.
On the other hand, age associated altered vascular ion channel
remodeling indicated decreased BK channel function as age increased (Toro et
al., 2002). Specifically, both rat and human coronary artery smooth muscle cells
have been shown to decrease in BK current density and α subunits protein
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content over time (Marijic et al., 2001). Additionally, age associated reduced BK
channel β1 subunits and the mechanisms of aged associated reduced BK
channel current density were reported later (Nishimaru et al., 2004a).
Interestingly, a study has demonstrated that age associated decreased BK
channel function has been attenuated by exercise training (Albarwani et al.,
2010). Therefore, age associated BK channel dysfunction is not an irreversible
phenomenon, and therapeutic benefits can be expected from exercise or
pharmacological approaches. Surprisingly, decreased BK channel expression
with aging was not evident in aged cerebral artery smooth muscle cells
(Nishimaru et al., 2004b). Thus, BK channel remodeling mechanisms
compensate for age associated dysfunctional vasculature depending on the
particular vascular bed, and they could be great pharmacological targets.
Diabetes and metabolic syndrome related to vascular dysfunction is
associated with altered BK channel function (Dimitropoulou et al., 2002; Lu et al.,
2005; Zhou et al., 2005; Burnham et al., 2006; McGahon et al., 2007; Borbouse
et al., 2009). Some studies indicate that alterations in signaling mechanisms,
such as arachidonic acid mediated signaling, result in impaired BK channel
function, but not BK channel expression (Dimitropoulou et al., 2002; Lu et al.,
2005). Other studies demonstrate that BK channel biophysical properties
including channel kinetics, sensitivities to voltage, and Ca2+ are impaired with
diabetic vessels (Burnham et al., 2006; Lu et al., 2008). On the other hand,
altered BK channel expression in diabetes has also been reported (McGahon et
al., 2007; Borbouse et al., 2009). Based on these multiple levels of observation,
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diabetes and metabolic syndrome associated altered vascular BK channel
function is associated with the combination of altered BK channel upstream
signaling, biophysical properties of BK channel and BK channel expression.

Issues in studying BK channels
BK channel antagonists/agonists
In addition to wide expression of BK channel in human tissue, the
numbers of chemical factors including ethanol (Dopico et al., 1998), hormones
(Valverde et al., 1999; Lovell et al., 2004; King et al., 2006) and xenoestrogens
(Dick et al., 2001; Coiret et al., 2007) have been shown to modulate BK channel
function. Particularly, ethanol is often used as a solvent for a variety of drugs and
it requires careful control for assessment of BK channel function when ethanol is
used for vehicle of the drug. Common experimental approaches to assess the
role of BK channel are pharmacological and genetic manipulation, however, each
approach possess a limitation.
A traditional pharmacological approach has been utilized to study the role
of BK channel in physiological function before the gene disruption technology
was established. Since the identification of peptide toxin including charybdotoxin
(ChTX) and iberiotoxin (IBTX) (Miller et al., 1985; Galvez et al., 1990) from
scorpion venom, both peptide toxins have been used to study the role of K+
channels in physiological function. Particularly, IBTX has been used as the gold
standard to elucidate the physiological role of BK channel as well as the
mechanism of gating because IBTX is highly selective to BK channel where
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ChTX is sensitive to other type of K+ channels (Galvez et al., 1990). Although
IBTX is recognized as a gold standard for BK channel inhibitor, several
limitations exist. Originally, the potency of IBTX to BK channel was reported as
IC50 pM to nM ranges (IC50 250 pM: (Galvez et al., 1990)), (IC50 1.7
nM:(Kaczorowski et al., 1996), however, a recent study has shown the IC50 of
IBTX is much higher (371 nM) (Lippiat et al., 2003) than the concentrations
commonly used to assess the physiological role and biophysical properties of BK
channels. Furthermore, IBTX is prohibitively expensive and its membrane
impermeable characteristics make IBTX difficult to use in whole animal studies.
Recently, a group of indole diterpenes has been reported as potent BK
channel inhibitors (Knaus et al., 1994b); which gave a hope to overcome some of
the limitations of IBTX, however, the pharmacological properties of each
compound seem to be distinctive and have not been fully explored. For instance,
some of these mycotoxins are tremorgenic indole alkaloids, but some are
nontremorgenic such as paspalinine (Knaus et al., 1994b). Within a group of
these mycotoxins, inhibitory effects of paxillne in BK channel have been relatively
well characterized (Sanchez & McManus, 1996). In the original report of the
effect of indole diterpenes on BK channel (Knaus et al., 1994b), it was mentioned
that paxilline weakly blocks delayed rectifier potassium channels in mouse
pancreatic β cells. Furthermore, paxilline has been reported to block Ca2+
activate Cl- channels (Sones et al., 2009). Penitrem A is also one of a group of
tremorgenic mycotoxins that have been shown to affect the central nervous
system by altering the release of neurotransmitters (Norris et al., 1980). The

23

ingestion of penitrem A has been associated with neurological disorders such as
tremor, ataxia and convulsions in dogs and humans (Eriksen et al.; Lewis et al.,
2005), However, in terms of the effect on BK channels, very little data regarding
the effect of penitrem A on BK channel and on vasculature tone are available.
A few BK channel agonists have been identified and characterized by
patch clamp experiments. For instance, NS004 (1-(2-hydroxy-5-chlorophenyl)-5trifluoromethyl-2- benzimidazolone) has been shown to increase open probability
of BK channel and its open dwell time (Olesen et al., 1994b). Additionally, the
effects of NS 1619 on BK channel have been well characterized (Edwards et al.,
1994; Olesen et al., 1994a) and utilized as well accepted BK channel opener in a
variety of studies. Although NS 1619 has been utilized as a BK channel agonist,
the issues in the selectivity of NS 1619 have been reported (Holland et al., 1996).
It has been shown that NS 1619 not only activates BK channel, but also inhibits
L-type Ca2+ channel activity. Therefore, it requires careful interpretation in
vasodilation response when NS1619 is used for the analysis of BK channel
function.

BK channel KO mice
As a recent subject of experimental popularity, the genetic modification
approach has become the major experimental design; however, there are certain
limitations to this approach, such as compensatory alteration to accommodate a
gene disruption (Faraci & Sigmund, 1999). Indeed, constitutive BK α subunit KO
mice and smooth muscle specific BK α subunit KO mice exhibit different degrees

24

of compensatory proteomic adaptions that resulted in more severe disruption in
urinary bladder function from smooth muscle specific BK α subunit KO mice
(Sprossmann et al., 2009). Furthermore, inter-laboratory variability exists in
experimental results using other transgenic mice. For instance, BK β1 subunit
KO mice were originally reported as hypertensive (Brenner et al., 2000; Pluger et
al., 2000) but a recent study contradicted these original reports (Xu et al., 2011).
Thus, although the utilization of BK channel KO mice in experiments is
increasing, a combination of traditional pharmacological approaches to inhibit or
activate BK channel to elucidate a role of BK channel in physiological and
pathophysiological conditions is critical.

Significance of study
Although there is no clear consensus on the adverse health effects of
BPA, evidence suggests that BPA may be associated with variety of pathologies
including carcinogenesis, altered reproductive function, and developmental
issues (Wetherill et al., 2005; Savabieasfahani et al., 2006; Vandenberg et al.,
2007; Hugo et al., 2008). Fetuses, infants, and children are more susceptible to
effects of BPA; however, a recent epidemiologic study revealed that BPA
exposure might be related to cardiovascular disease in adults (Lang et al.,
2008b). Because BPA exposure is increasing and these phenomena will
continue to intensify, early and conclusive studies on safety and mechanism are
needed to prevent public health hazards like the ones created by asbestos and
DDT. This project will generate meaningful data useful to the Food and Drug
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Administration and the National Toxicology Program in assessing BPA toxicity
and providing regulatory guidance. Since possible links between BPA and
disease have appeared relatively recently, controversies and confusion exist
regarding its health effects. There is not enough scientific evidence to draw an
accurate conclusion as to whether BPA exposure is linked to cardiovascular
disease; however, alterations of BK channel function and expression are
associated with coronary dysfunction related to hypertension (Brenner et al.,
2000; Amberg & Santana, 2003), diabetes (Lu et al., 2008; Borbouse et al.,
2009), and aging (Nishimaru et al., 2004a). Our contribution will be a detailed
analysis of cellular and molecular effects of BPA on BK channels of vascular
smooth muscle cells. We will elucidate molecular pharmacological and
toxicological effects of BPA on BK channels; specifically, we will identify genomic
and non-genomic mechanisms of BPA effect on BK channels in vascular smooth
muscle cells.

Summary
In conclusion, although BPA has been utilized in industry because original
toxicological studies conclude that the level of exposure to human is below the
levels of observed adverse effect, recent studies raised concerns regarding the
association with BPA and a number of pathologies. We hypothesize that BPA
can alter BK channel function and expression via genomic/non-genomic
mechanisms. With regard to our hypothesis, we also raised the issues in studies
assessing the function of BK channel. Thus, we will characterize the new BK

26

channel inhibitor, penitrem A, and utilize penitrem A to identify the novel
mechanisms of BPA induced altered BK channel function. These alterations may
explain the link to the BPA exposure and BPA associated increased risk of
cardiovascular diseases.
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Abstract
Large conductance, Ca2+/voltage-sensitive K+ (BK) channels are well
characterized, but physiological roles, often determined through pharmacological
manipulation, are less clear. Iberiotoxin is considered the “gold standard”
antagonist, but cost and membrane-impermeability limit usefulness. Economical
and membrane-permeable alternatives could facilitate the study of BK channels.
Thus, we characterized the effect of penitrem A, a tremorgenic mycotoxin, on BK
channels and demonstrate utility for studying vascular function in vitro and in
vivo. Whole-cell currents from HEK 293 cells transfected with hSlo α or α + β1
were blocked >95% by penitrem A (IC50 6.4 vs. 64.4 nM; p<0.05). Further,
penitrem A inhibited BK channels in inside-out and cell-attached patches,
whereas iberiotoxin could not. Inhibitory effects of penitrem A on whole-cell K+
currents were equivalent to iberiotoxin in canine coronary smooth muscle cells.
As for specificity, penitrem A had no effect on native delayed rectifier K+ current
in canine coronary smooth muscle, cloned human KV1.5 channels, or pinacidilinduced relaxation of canine coronary arteries. Penitrem A enhanced sensitivity
to K+-induced contraction in canine coronary arteries by 23 ± 5% (p<0.05) and
increased the blood pressure response to phenylephrine in anesthetized mice by
36 ± 11% (p<0.05). Our data indicate that penitrem A is a useful tool to study the
role of BK channels in vascular function and is practical for cell and tissue (in
vitro) studies as well as anesthetized whole animal (in vivo) experiments.

40

Introduction
Large conductance, Ca2+/voltage-sensitive (BK) channels, composed of
pore forming α and auxiliary β1 subunits, may be key regulators of arterial tone
via negative feedback (Nelson et al., 1995; Jaggar et al., 2000). Indeed, altered α
or β1 expression is associated with vascular dysfunction in hypertension,
diabetes, and aging (Liu et al., 1998; Brenner et al., 2000; Amberg et al., 2003;
Borbouse et al., 2009). Genetic deletion of α or β1 subunits produces
hypertension; however, in addition to presumed changes total peripheral
resistance, the role of adrenal BK channels to regulate aldosterone production
must also be considered (Cysewski et al., 1975; Sausbier et al., 2005). In
contrast to the original report (Brenner et al., 2000), a recent study indicated that
β1 knockout mice are normotensive (Xu et al., 2011). Thus, much remains to be
determined about the physiological roles of BK channels and/or compensations
in response to BK channel gene deletion.
Adding complexity to our understanding of BK channel function is
heterogeneity between vascular beds (Yang et al., 2009). While BK channels
appear extremely important in regulating cerebral vascular tone (Brayden &
Nelson, 1992; Knot et al., 1998), these channels are arguably less important in
skeletal muscle arteries (Kotecha & Hill, 2005; Yang et al., 2009) or coronary
arteries (Rogers et al., 2006; Borbouse et al., 2010a; Borbouse et al., 2010b).
Clearly, the regulation of BK channels is extremely complex and governed by
multiple endogenous signaling molecules (Hou et al., 2009). Thus, understanding
the physiological roles and mechanisms of BK channel activation will require
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additional research using a combination of genetic models and pharmacological
tools.
Since the identification and characterization of peptide toxins in scorpion
venom, iberiotoxin has become the “gold standard” for pharmacological study of
BK channels due to selectivity and potency (IC50 0.25 nM) (Galvez et al., 1990).
However, a recent study determined the IC50 of iberiotoxin is much higher (33371 nM) than the concentrations commonly used (Lippiat et al., 2003).
Additionally, iberiotoxin is prohibitively expensive for many isolated organ and
whole-animal studies and its membrane-impermeability creates difficulty for cellattached or inside-out patch clamp experiments. It would be beneficial to identify
an economical and membrane-permeable alternative to facilitate physiological
and pharmacological studies of BK channels. Penitrem A is one such candidate
molecule (Knaus et al., 1994) and has been used previously as an inhibitor of BK
channels in smooth muscle (Cotton et al., 1997; Borbouse et al., 2009; Asano et
al., 2010).
Little, however, is known about the basic pharmacological properties of
penitrem A. For example, the IC50 for block of BK channels has not been
published, nor are there reports of its specificity in regard to other K+ channels.
Our study was designed to characterize some pharmacological properties of
penitrem A as a BK channel antagonist and to demonstrate utility in determining
the physiological role of BK channels in vascular smooth muscle. Experiments
were performed at the cell, tissue, and whole animal level. We used patch clamp
techniques to assess the inhibitory effect, determine whether the β1 subunit
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influenced block, and illustrate advantages of a membrane-permeable inhibitor.
We measured the isometric tension of coronary arteries and the blood pressure
of anesthetized mice to determine whether penitrem A altered vascular reactivity
in vitro or in vivo. We conclude that penitrem A, compared to iberiotoxin, is an
antagonist of BK channels that is comparable in potency and efficacy, but is
more useful and less expensive.
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Methods
Animal models
All animal procedures and protocols were approved by institutional committees
and followed guidelines set forth in the Guide for the Care and Use of Laboratory
Animals (National Academy Press, 2011). Male C57BL/6 mice 10-12 weeks of
age were used for in vivo blood pressure experiments. As described below, mice
were anesthetized to a surgical plane of anesthesia prior to experiments and
euthanized thereafter. Coronary arteries from male mongrel dogs were used for
in vitro isometric tension experiments as described previously (Rogers et al.,
2006). In brief, anesthetized dogs were used for unrelated experiments involving
a thoracotomy; the heart was fibrillated and removed to isolate coronary arteries.
For patch clamp experiments on native vascular smooth muscle cells, arteries
were obtained from a variety of different species (rat, mouse, dog, and pig).
Arteries (cerebral, coronary, femoral, and aorta) were taken from animals
euthanized following unrelated experiments.

Cell culture and transfection
HEK 293 cells (Stratagene, La Jolla, CA) were grown in Dulbecco’s Modified
Eagle Medium supplemented with 10% FBS, 100 units/ml penicillin, 100 µg/ml
streptomycin, and culture flasks were incubated in a 5% CO2 incubator at 37 °C.
Plasmids encoding hSlo α and hSlo α + β1 were kindly provided by Dr. Jonathan
Lippiat (Lippiat et al., 2003) and hKV1.5 plasmid was a generous gift from Dr.
Jeffrey R Martens (McEwen et al., 2007). Cells were transiently transfected with
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pIRES-hSloα or pIRES-hSloαβ1 and pmaxGFP (AMAXA, Gaithersburg, MD)
using Lipofectamine LTX with PLUS reagent (Invitrogen, Carlsbad, CA). Cells at
50-70% confluence in 35 mm dishes were transfected with 0.5-2.5 mg of DNA
and currents were recorded from GFP positive cells 1-3 days later. Transfected
cells were selected in media supplemented with 0.5 mg/ml G418 (Invitrogen,
Carlsbad, CA), 1% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin.

Electrophysiology
BK channel currents were recorded at room temperature from inside-out and
whole-cell patches as previously described (Asano et al., 2010). The bath flowed
~2-3 ml/min into a ~0.2-0.3 ml chamber throughout the recordings. For whole-cell
recordings, bath solution contained (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10
glucose, 10 HEPES, and 5 Tris; pH 7.4. Pipette solution contained (mM) 140
KCl, 1 MgCl2, 1 EGTA, 10 HEPES, 1 Mg-ATP, 0.1 Na-GTP and 5 Tris; pH 7.1.
Inside-out recordings were made in symmetrical (mM) 140 KCl, 1 MgCl2, 1
EGTA, 10 HEPES, 5 Tris; pH 7.1; pCa 7 (Maxchelator; http://www.stanford.edu/
~cpatton/maxc.html). Stock solutions of penitrem A (MP Biomedicals, Solon, OH)
were prepared in DMSO and diluted for 1:10,000 for experiments. Iberiotoxin
(AnaSpec, San Jose, CA) was dissolved in water and diluted 1:1000 for
experiments.

Isometric tension studies
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Isometric tension was measured from segments of canine left circumflex
coronary arteries as described previously (Rogers et al., 2006). Arteries were
denuded of endothelium and the lack of a relaxant response to acetylcholine (10
µM) in pre-contracted arterial tissue confirmed the functional loss of endothelium.
For the pinacidil concentration-response experiments, arteries were precontracted with 1 µM U46619, a thromboxane A2 mimetic, and the relaxation
elicited by cumulative additions of pinacidil in the presence or absence of 1 µM
penitrem A. For the K+ concentration-response experiments, KCl was added
cumulatively in the presence or absence of 1 µM penitrem A.

Blood pressure measurements
Mean arterial pressure was measured as described previously (Ohanyan et al.,
2011). Mice were anesthetized with sevoflurane gas (supplemented with O2) and
placed on a heating table to maintain body temperature at 37 °C. A polyethylene
catheter was placed into the jugular vein for bolus administrations of heparin (50
U/ml) and hexamethonium (5 mg/kg), a ganglionic blocker. A micro-tip transducer
(Millar Instruments, Houston, TX) was placed in the femoral artery to measure
mean arterial pressure and heart rate. Data were recorded with a Power Lab
acquisition system (ADInstruments, Colorado Springs, CO). Phenylephrine (0.5
µg/kg/min) and penitrem A (100 µg/kg/min) were administered intravenously.
Stock solutions of penitrem A were dissolved in ethanol and subsequently diluted
in lactated Ringer’s solution; phenylephrine was diluted in lactated Ringer’s
solution.
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Statistics
Data are presented as the mean and standard error of n number of samples
(e.g., number of patches, cells, dogs, or mice as described in the text and figure
legends). When two values were compared, paired or unpaired t-tests were used
as appropriate. When three values were compared, one-way analysis of variance
(ANOVA) was used. Current-voltage relationships and concentration-response
curves were analyzed by two-way ANOVA. Bonferroni post hoc tests followed
ANOVA to determine differences. In all tests, p<0.05 was considered significant.
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Results
Penitrem A inhibits BK channels in a concentration-dependent manner:
influence of the β1 subunit.
Whole-cell patch clamp techniques were used to determine the effect of penitrem
A on cloned BK channels (α or α + β1) expressed in HEK 293 cells. Currents at
+100 mV were recorded under control conditions (in the presence of vehicle;
0.01% DMSO) and after addition of penitrem A (Fig. 1A & B). In cells expressing
BK channels composed solely of α subunits, inhibition of current by 100 nM
penitrem A was 93 ± 1% (n = 13 cells; Fig. 1A&C). In contrast, when BK
channels contained the regulatory β1 subunit, block by 100 nM penitrem A was
only 41 ± 9% (n = 9 cells; Fig. 1B&C). Over several log orders of penitrem A
concentrations, BK channels composed of α subunits alone were more sensitive
to block than BK channels containing the β1 subunit (Fig. 1C). The half-maximal
inhibitory concentration (IC50) of penitrem A for BK α was 6.4 nM (log IC50 = -8.20
± 0.08; n = 7-16 cells). The IC50 of penitrem A on BK α + β1 subunits was 64.4
nM (log IC50 = -7.19 ± 0.07; n = 4-15 cells; p<0.05). Hill slopes were equivalent (0.91 ± 0.12 vs. -1.07 ± 0.15). In addition to reduced sensitivity, the time course of
channel block by penitrem A was slowed by the β1 subunit (Fig. 1D & E). The
inhibitory effect of penitrem A on BK channel current was, for all practical
purposes, irreversible (Fig. 2). When current in cells expressing BK channels
composed of α + β1 subunits was inhibited by 1 µM penitrem A, 10 or more min
of washing was insufficient time for appreciable reversal (Fig. 2A). After 2 min of
penitrem A (1 µM) exposure, current was inhibited 91 ± 2% (n = 5; Fig. 2B). Cells
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were studied in a ~0.2-0.3 ml chamber that was perfused at ~2-3 ml/min;
however, washing cells for 14 min with penitrem A-free bath solution did not
allow BK current to recover (Fig. 2B; current at the 20 min mark was only 6 ± 2%
of the control level). Similar irreversibility was observed in native smooth muscle
cells (e.g., rat aorta) with lower concentrations of penitrem A (e.g., 50 nM; Fig.
2C & D).

Penitrem A, but not iberiotoxin, inhibits BK channels in inside-out patches.
Iberiotoxin blocks BK channels by “plugging” the pore from the extracellular side
(Giangiacomo et al., 1992); therefore, one cannot use bath application of
iberiotoxin to block BK channels in cell-attached or inside-out patches. A
common strategy to overcome this limitation is to backfill patch pipettes with
iberiotoxin, thus allowing some time for control measurements while iberiotoxin
diffuses to the tip. A membrane-permeable BK channel antagonist could
strengthen experimental design and allow more time for control measurements
and/or interventions prior to BK channel block. We compared the effects of
iberiotoxin (100 nM) and penitrem A (100 nM) on BK channels in cell-attached
and inside-out patches (Fig. 3). As expected, bath application of iberiotoxin to
inside-out patches of had no inhibitory effect on BK channel activity. In contrast,
bath application of penitrem A inhibited BK channel activity in inside-out patches.
Mean NPo of BK α alone under control conditions, with iberiotoxin, and with
penitrem A was 0.077 ± 0.040, 0.103 ± 0.076, and 0.002 ± 0.001, respectively.
(p<0.05 for penitrem A, n = 7-10). Similarly, mean NPo of BK α + β1 under control

49

conditions, with iberiotoxin, and with penitrem A was 0.401 ± 0.158, 0.564 ±
0.235, 0.015 ± 0.014 (p<0.05 for penitrem A, n = 7-13). Like the whole-cell
recordings, BK channel block by penitrem A was not readily reversible with
extensive washing. In contrast to the whole-cell recordings where 100 nM
penitrem A inhibited BK α + β1 by less than half (Fig. 1), 100 nM penitrem A
inhibited BK α + β1 in inside-out patches by 97 ± 1%. This increased inhibitory
effect at the cytoplasmic face was also noted in the original description of
penitrem A (Knaus et al., 1994).

Specificity of penitrem A: block of BK, but not KV or KATP channels.
The effect of penitrem A to inhibit K+ current in coronary artery smooth muscle
cells is equivalent to iberiotoxin (Fig. 4). In coronary myocytes, penitrem A (300
nM) inhibited BK current significantly, and the remaining current appeared to be
mediated by KV channels (Fig. 4A & B). After penitrem A treatment, iberiotoxin
(100 nM) had no further inhibitory effect on current at +100 mV (Fig. 4C); when
iberiotoxin was added first, penitrem A had no further inhibitory effect (Fig. 4D). It
is unclear what KV channel type(s) mediate the delayed rectifier K+ currents in
smooth muscle, but KV1.5 has been suggested as a component (Chen et al.,
2006; Dick et al., 2008). Thus, we determined whether penitrem A could inhibit
cloned KV1.5 channels (Fig. 5A & B). Whole-cell recordings of KV1.5 current were
made from HEK 293 cells transfected with hKV1.5 plasmid (McEwen et al., 2007).
Penitrem A (1 µM) had no effect on KV1.5 channels; current at +60 mV in the
presence of penitrem A was 105 ± 6% of control (n = 5). We tested the effect of
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penitrem A on total outward K+ current in a variety of other native vascular
smooth muscle cells (Supplemental figure). In each species and tissue, penitrem
A (1 mM) inhibited BK current (i.e., strongly outwardly rectifying current at
positive potentials) and appeared to have little or no effect on native delayed
rectifier channels.
KATP channels are another major type of K+ channel in coronary smooth
muscle (Dart & Standen, 1995); therefore, we determined whether penitrem A
could inhibit KATP channels. Dog coronary arteries were contracted with U44619
(a thromboxane A2 mimetic; 1 µM) and relaxed with pinacidil, a KATP channel
opener. These experiments were performed in the presence or absence of
penitrem A (1 µM). Pinacidil-induced relaxation was unaffected by penitrem A
(Fig. 5C & D; arteries from n = 3 dogs; maximum relaxation 91 ± 5 vs. 94 ± 2%
and log IC50 = -5.94 ± 0.11 vs. -5.85 ± 0.07). We performed patch clamp
experiments to measure directly the effects penitrem A on pinacidil-induced KATP
current activation. Whole-cell current in mouse aortic myocytes (n = 6) was
measured at -50 mV in symmetrical 140 mM K+. Pinacidil (10 µM) activated 165
± 49 pA of inward current. Penitrem A (1 µM) had no effect on pinacidil-activated
current (87 ± 6% of control); however, glibenclamide (10 µM) inhibited pinacidilactivated current 80 ± 7% (p < 0.05).

Penitrem A augments smooth muscle contractility in vitro and in vivo.
To test penitrem A as a functional inhibitor of smooth muscle BK channels in
vitro, K+ concentration-response curves were constructed for coronary arteries in
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the presence or absence of 1 µM penitrem A. Inhibition of BK channels produced
a leftward shift in the K+ concentration-response curve (Fig. 6). Contractions with
20, 30, and 40 mM K+ were increased 79 ± 12, 26 ± 5 and 12 ± 4% by blocking
BK channels with 1 µM penitrem A (p<0.05; arteries from n = 8 dogs). To test
penitrem A as a functional inhibitor of smooth muscle BK channels in vivo, blood
pressure responses to phenylephrine, an a1 adrenergic agonist, were measured
in anesthetized mice. Hexamethonium (5 mg/kg i.v.), a nicotinic receptor
antagonist, was used to eliminate reflex responses to blood pressure changes.
Phenylephrine (0.5 µg/kg/min i.v.) increased blood pressure to a steady state
level and then addition of penitrem A (100 µg/kg/min) increased blood pressure
further (Fig. 7A). In 5 mice (Fig. 7B), phenylephrine increased mean blood
pressure from 57 ± 2 to 77 ± 1 mmHg (p<0.05), while the addition of penitrem A
further increased blood pressure to 84 ± 3 mmHg (p<0.05 vs. control and
phenylephrine).
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Discussion
The objective of this study was to better characterize penitrem A as an
inhibitor of BK channels (Knaus et al., 1994). Penitrem A has been used
previously as inhibitor of BK channels in smooth muscle (Cotton et al., 1997;
Borbouse et al., 2009; Asano et al., 2010). Importantly, however, employment of
penitrem A as a BK channel antagonist has been without a complete
understanding of its pharmacological properties. For example, the IC50 was not
known and it was unclear whether BK channel subunit composition might affect
the block. We show that penitrem A inhibits BK α and α+ β1 with IC50 values of
6.4 and 64.4 nM (Fig. 1) Additionally, the use of penitrem A to study BK channels
has been, until recently (Borbouse et al., 2009; Borbouse et al., 2010a; Borbouse
et al., 2010b), limited to in vitro studies, particularly patch clamp experiments.
Thus, we further investigated penitrem A as a BK channel inhibitor to assess
vascular function in vitro and in in vivo. We show that penitrem A enhances
smooth muscle contraction in vitro (Fig. 6) and increases total peripheral
resistance in vivo (Fig. 7). Information regarding the specificity of penitrem A
against other ion channels was limited to Ca2+-activated Cl- channels (Sones et
al., 2009), where it had very little effect. Here we demonstrate no effect of
penitrem A on native delayed rectifier, cloned KV1.5, or KATP channels (Figs. 4
and 5 and Supplement). Iberiotoxin and penitrem A are roughly equivalent in
potency and efficacy (Fig. 4 and Table 1), but penitrem A is less than 0.1% of the
cost on a per mole basis. We conclude that penitrem A is comparable to
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iberiotoxin in potency, efficacy, and selectivity and, further, that penitrem A can
be a more useful and economical alternative.
BK channel subunit knockout mice have become a popular experimental
model for studying smooth muscle reactivity and a great deal of important
information has been gleaned; however, this approach comes with certain
limitations. For example, deletion of K+ channel genes elicits phenotypic
compensations that may compromise interpretation (Nerbonne et al., 2008).
Such changes may explain variable observations regarding blood pressure in BK
channel subunit knockout mice. For instance, BK β1 subunit knockout mice were
originally reported as hypertensive (Brenner et al., 2000; Pluger et al., 2000), but
a recent study contradicted this (Xu et al., 2011). The earlier studies included
acute measurements of blood pressure in conscious mice with arterial catheters,
whereas the later study used radiotelemetry to monitor blood pressure
continuously for 1 wk. Both approaches are valid and it remains unknown
whether differences in the method of blood pressure measurement or the
response to stress could explain the discrepancies; however, compensatory
changes in other K+ channels or physiological mechanisms might be responsible
for observations of normal blood pressure in BK β1 subunit knockout mice. An
alternative explanation is that BK channels may play a minimal role in regulating
total peripheral resistance. Thus, the power of traditional pharmacological
approaches to inhibit BK channels in order to elucidate a mechanism of action
should not be underestimated, as we (Borbouse et al., 2009; Borbouse et al.,
2010a; Borbouse et al., 2010b) and others (Node et al., 1997) have previously
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demonstrated little, if any role, for BK channels in regulating coronary vascular
tone using penitrem A, charybdotoxin, or iberiotoxin. No comparable studies of
organ blood flow are available for BK channel subunit knockout mice; this is likely
due to the difficulty of instrumenting small animals. Studies of BK channels in
regional and systemic hemodynamics might be made more readily in larger
animals by employing suitable pharmacological tools such as paxilline, lolitrem B,
and penitrem A (Table 1). It must be kept in mind, however, that penitrem A was
first reported in the literature due to its tremorgenic effects; therefore, its use in
vivo may best be limited to anesthetized animals because of potential
neurological side effects and convulsant properties.
Some characteristics of BK channel block by penitrem A are compared to
those of other BK channel antagonists in Table 1. It is important to note that while
experimental details such as patch potential and free Ca2+ are not identical, a
fairly consistent picture emerges. Moreover, our data were generated using the
plasmids of Lippiat and colleagues (2003), allowing a relatively direct
comparison. Penitrem A appears to be one-half to one log order more potent
than iberiotoxin, while the presence of β1 subunits reduces sensitivity to either
agent by a factor of 10. All of the pharmacological tools characterized in Table 1
block BK channels with similar efficacy (>95%). Penitrem A can inhibit BK
channels whether it is applied from intracellular or extracellular side of the
membrane; this property is shared by paxilline and lolitrem B, but not iberiotoxin.
We found that β1 subunits decrease BK channel sensitivity to penitrem A. This is
different from paxilline or lolitrem B, which block BK α, α + β1, and α + β4 with
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similar potency (Imlach et al., 2008). Specificity for BK channels is another issue
surrounding the available antagonists. Paxilline has been reported as an inhibitor
of Ca2+-activated Cl- channels, whereas penitrem A and iberiotoxin have much
less effect (Sones et al., 2009). In the original report (Knaus et al., 1994), it was
mentioned that paxilline weakly blocks delayed rectifier K+ channels in mouse
pancreatic β cells, but we show here that penitrem A has no effect on native
delayed rectifier, cloned KV1.5, or KATP channels (Fig. 4 and 5). More studies will
be necessary to determine possible off-target interactions of penitrem A; these, if
any, may be expected to arise from introducing penitrem A into complex systems
such as isolated organ or whole animal experiments.
Importantly, however, the effects of penitrem A we observed in isolated
arteries in vitro and on blood pressure in vivo were relatively straightforward and
can be interpreted as specific effects on BK channels (Figs. 6 and 7). For
example, in Fig. 6, the effect of penitrem A to increase smooth muscle
contraction is consistent with what has been reported previously for iberiotoxin
(Brayden & Nelson, 1992; Bratz et al., 2005). We assessed the effect of penitrem
A on smooth muscle tone in vivo by measuring blood pressure in anesthetized
mice (Fig. 7). C57BL/6 mice are a common background for engineered mice;
therefore, these data may be a reference for those interested in using penitrem A
in knockout or transgenic mice. A recent study demonstrated that lolitrem B had
no effect on blood pressure, but decreased heart, in mice (Imlach et al., 2010).
Our first impression was that these results could be explained by a reflex
adjustment of heart rate, and thus cardiac output, and ultimately blood pressure
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in response to an increase in total peripheral resistance. However, Imlach et al.
went on to demonstrate an inhibitory effect of lolitrem B on heart rate in
Langendorff-perfused hearts, where neural input is removed. The mechanism(s)
by which lolitrem B reduces heart rate are unknown; however, it is important to
note that they are not shared by penitrem A. We used hexamethonium to block
autonomic responses and heart rate was unchanged during penitrem A-induced
increases blood pressure (Fig. 7).
We demonstrated the efficacy and selectivity of penitrem A on BK channel
function in vitro and in vivo; however, our study has several limitations that need
to be addressed. First, penitrem A is well known to cause muscle tremor, thus,
the use of penitrem A to study the role of vascular BK channels might best be
limited to anesthetized animals for in vivo experiments. Second, in addition to
vascular smooth muscle BK channels, systemic penitrem A administration will
inhibit BK channels in other cells and tissues that might affect the regulation of
vascular tone and blood pressure. For instance, a recent study indicated that BK
channels in astrocytes are key regulators of neurovascular coupling (Girouard et
al., 2010). Additionally, BK channels in endothelium may regulate membrane
potential, Ca2+ influx, and the production of relaxing factors (Sandow & Grayson,
2009). Since BK channel expression is ubiquitous, in vivo experiments with
penitrem A will require careful design and interpretation.
In conclusion, we have further characterized penitrem A as an inhibitor of
BK channels, particularly BK a + b1 channels that are generally found in smooth
muscle. This information could be put to important use determining the roles of
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BK channels in vascular function and serve as a complement to studies
performed in BK channel subunit knockout mice. We demonstrate that penitrem
A is a useful and economical alternative for studying the role of BK channels in
vitro and in vivo. That is, we show that that the use of penitrem A is not limited to
patch clamp experiments, rather this agent is practical for tissue, organ, and
whole animal studies.
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Legends for figures
Fig. 1 Presence of the β1 subunit decreases the sensitivity of BK channels
to penitrem A. Representative traces of BK current at +100 mV in HEK 293 cells
transfected with hSlo α (Panel A) or hSlo α + β1 (Panel B). Whole-cell current
was measured before (control) and after addition of penitrem A (100 nM). Group
data (Panel C; n = 4-16 cells at each concentration) show the effect of BK
channel subunit composition on sensitivity to block by penitrem A. Asterisks
indicate p<0.05 between the two groups as determined by two-way ANOVA.
Group data (n = 3-9) show time- and concentration-dependent block of BK a
(Panel D) and α + β1 (Panel E) by penitrem A. Note that, compared to a, a 10x
higher concentration of penitrem A is required to achieve a similar timedependent block in α + β1.

Fig. 2 Irreversible block of BK channels by penitrem A. Current traces are
shown from a representative HEK 293 cell expressing BK channels composed of
α + β1 subunits (Panel A). The voltage template used is shown below the
current. Penitrem A (1 µM) abolished current within 1-2 min; however, 10 min of
washing in penitrem A-free bath solution was not sufficient time for current to
recover appreciably. (Panel B) Group data (n = 5 cells) illustrate the practical
irreversibility of a 2 min exposure to penitrem A; BK current at +100 mV is plotted
vs. time. Current traces are shown from a representative rat aortic smooth
muscle cell (Panels C and D). The voltage template was same as above.
Penitrem A (50 nM) reduced native BK current and was practically irreversible.
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Fig. 3 Penitrem A blocks BK channels in inside-out and cell-attached
patches. Recordings of channel activity from representative inside-out patches
are shown for BK α (Panel A) or α + β1 (Panel B). Patch potential was +40 mV
and solutions were symmetrical 140 mM K+ with 100 nM free Ca2+. Channel
activity was recorded under control conditions and with bath application of
iberiotoxin (100 nM) or penitrem A (100 nM). (Panel C) Penitrem A blocks BK
channel (α + β1) activity in a cell-attached patch. Channel activity was recorded
under control conditions and with bath application of penitrem A (100 nM). (Panel
D) Group data (n = 23 patches) show that the exposure of the cytosolic side of
inside-out patches to penitrem A, but not iberiotoxin, inhibits BK channel activity.
Asterisk indicates p<0.05 vs. control by one-way ANOVA.

Fig. 4 Iberiotoxin and penitrem A block the same current in canine coronary
smooth muscle cells. (Panel A) Families of current traces from a representative
dog coronary artery smooth muscle cell are shown under control conditions, with
penitrem A (300 nM), and with iberiotoxin (100 nM). These experiments were
performed with a bath solution containing 0.01% bovine serum albumin to limit
nonspecific binding of iberiotoxin to plastic. (Panel B) The I-V relationships from
traces in A are shown. Penitrem A and iberiotoxin block the same current (inset).
(Panel C) Group data (cells from n = 5 dogs) demonstrate that penitrem A blocks
iberiotoxin-sensitive current; current at +100 mV is shown. (Panel D) Similarly,
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iberiotoxin blocks penitrem A-sensitive current at +100 mV. Asterisks indicate
p<0.05 vs. control by one-way ANOVA.

Fig. 5 Penitrem A has no effect on KV1.5 or KATP channels. (Panel A) Wholecell recordings were made from HEK 293 cells transfected with hKV1.5.
Representative KV1.5 currents in the absence or presence of 1 µM penitrem A.
(Panel B) Group data (n = 5 cells) show that penitrem A (1 µM) has no effect on
KV1.5 current. (Panel C) Representative isometric tension recordings show that
penitrem A (1 µM) does not inhibit pinacidil-induced relaxation. (Panel D) Group
data (arteries from n = 3 dogs) show that penitrem A (1 µM) has no effect on KATP
channels. Arteries were contracted with 1 µM U46619 and relaxed with
cumulative additions of pinacidil.

Fig. 6. Penitrem A selectively inhibits BK channel to alter vascular
contraction from in vitro vascular functional experiments.
Panel A) Representative traces for KCl induced contraction with/without penitrem
A are shown. (Panel B) Group data showed a leftward shift in contraction
response with penitrem A. Asterisks (*) indicate significant difference (p< 0.05)
from control by two-way ANOVA.

Fig. 7 Block of BK channels by penitrem A augments phenylephrineinduced blood pressure responses in mice. (Panel A) Mean arterial pressure
and heart rate are shown for a representative mouse. The mouse received
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phenylephrine (0.5 µg/kg/min i.v.), which increased pressure. There was no
reflex change in heart rate, as the ganglionic blocker hexamethonium (5 mg/kg
i.v.) was injected prior to the experiment. Penitrem A (100 µg/kg/min i.v.) was
added and increased pressure further. (Panel B) Group data (n = 5 mice)
illustrate effect of penitrem A to augment phenylephrine-induced pressor
responses. Asterisk and dagger indicate significant difference (p<0.05) from
control and phenylephrine, respectively, by one-way ANOVA.
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Figure 2 1 Presence of the β1 subunit decreases the sensitivity of BK
channels to penitrem A
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Figure 2 2 Irreversible block of BK channels by penitrem A
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Figure 2 3 Penitrem A blocks BK channels in inside-out and cell-attached
patches.
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Figure 2 4 Iberiotoxin and penitrem A block the same current in canine
coronary smooth muscle cells.
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Figure 2 5 Penitrem A has no effect on KV1.5 or KATP channels.

70

Figure 2 6 Penitrem A selectively inhibits BK channel to alter vascular
contraction from in vitro vascular functional experiments
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Figure 2 7 Block of BK channels by penitrem A augments phenylephrineinduced blood pressure responses in mice
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Table 2 1 Characteristics of BK channel blockers

Supplemental Data
We determined the effect of penitrem A on K+ currents in a variety of native
vascular smooth muscle cells. The point of these experiments is to demonstrate
that penitrem A (1 µM) inhibits the same type of strongly outwardly rectifying
current without effect on native delayed rectifiers. Panels A-E show currents in
smooth muscle cells isolated from rat middle cerebral artery (n = 3), rat femoral
artery (n = 3), mouse aorta (n = 3), pig coronary artery (n = 5), and dog coronary
artery (n = 7). The voltage template (shown in A) was the same for all
experiments. Solutions for whole-cell currents are described in the Methods.
Panel F contains data showing that penitrem A 1 µM inhibits the a subunit cloned
from cow (courtesy of Dr. Michael Davis, University of Missouri) and expressed in
HEK 293 cells (n = 3).
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Figure 2 8 Supplemental Figure1 Penitrem A on K+ currents in a variety of
vascular smooth muscle cells
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Figure 2 9 Supplemental Figure2 Penitrem A on K+ currents in a variety of
vascular smooth muscle cells
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Abstract
Background and purpose: Bisphenol A (BPA) is used to manufacture plastics,
including food containers into which it leaches. High levels of exposure to this
estrogenic endocrine disruptor are associated with diabetes and heart disease.
Estrogen and estrogen receptor modulators increase the activity of large
conductance Ca2+/voltage-sensitive K+ (Maxi-K) channels, but the effects of BPA
on Maxi-K channels are unknown. We tested the hypothesis that BPA activates
Maxi-K channels through a mechanism that depends upon the regulatory β1
subunit.
Experimental approach: Patch clamp recordings of Maxi-K channels were made
in human and canine coronary smooth muscle cells as well as in AD-293 cells
expressing pore-forming α or α plus β1 subunits.
Key results: BPA (10 µM) activated an outward current in smooth muscle cells
that was inhibited by penitrem A (1 µM), a Maxi-K blocker. BPA increased Maxi-K
activity in inside-out patches from coronary smooth muscle, but had no effect on
single channel conductance. In AD-293 cells with Maxi-K channels composed of
α subunits alone, 10 µM BPA did not affect channel activity. When channels in
AD-293 cells contained β1 subunits, 10 µM BPA increased channel activity.
Effects of BPA were rapid (<1 min) and reversible. A higher concentration of BPA
(100 µM) increased Maxi-K current independent of the β1 subunit.
Conclusions and implications: These data indicate BPA increases the activity of
Maxi-K channels and may represent a basis for some potential toxicological
effects.
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Introduction
Although there is no clear consensus on detrimental health effects of BPA,
evidence suggests it possesses endocrine disrupting activity. BPA may affect
fetal and neonatal development (Vandenberg et al., 2007), reproductive function
(Savabieasfahani et al., 2006), metabolism (Hugo et al., 2008), and
carcinogenesis (Wetherill et al., 2002; Wetherill et al., 2005). A recent study
demonstrated an association between BPA levels and adverse cardiovascular
diagnoses (Lang et al., 2008). Environmental exposure through polycarbonate
plastic bottles, epoxy linings of canned foods, and dental sealants makes BPA a
potential public health hazard.
BPA interacts with nuclear estrogen receptors, although much less
potently than 17β-estradiol (Krishnan et al., 1993; Kuiper et al., 1997). BPA also
exerts nongenomic effects, independent of nuclear estrogen receptors. For
example, BPA rapidly disrupts intracellular Ca2+ homeostasis in a variety of cells
(Nadal et al., 2000; Alonso-Magdalena et al., 2005; Walsh et al., 2005). These
data suggest that BPA influences the activity of cellular transport mechanisms,
perhaps including ion channels. Importantly, however, there are no data available
regarding effects of BPA on the function of an ion channel per se. Maxi-K
channels offer themselves as an excellent model to test for interactions with
BPA, as they are estrogen-sensitive (Valverde et al., 1999).
Maxi-K channels, identified as KCa1.1 in the Guide to Receptors and
Channels (Alexander et al., 2008), are formed by 4 pore-forming α subunits
encoded by KCNMA1 (Butler et al., 1993); when β1 subunits are present,
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sensitivity to estrogenic substances is conferred (Valverde et al., 1999; Dick et
al., 2001; Dick & Sanders, 2001; Dick et al., 2002; Duncan, 2005; Coiret et al.,
2007). The majority of Maxi-K channels in vascular smooth muscle contain this
regulatory β1 subunit, encoded by KCNMB1 (Tanaka et al., 1997), which
increases Ca2+- and voltage-sensitivity (McManus et al., 1995; Meera et al.,
1996). Maxi-K channels (Nelson et al., 1995) and the β1 subunit (Brenner et al.,
2000) play key roles in regulating smooth muscle excitability. The present study
was designed to determine whether BPA activates Maxi-K channels and to
ascertain the role of the β1 subunit. We hypothesized that BPA would activate
Maxi-K channels through a mechanism that depends upon the β1 subunit. To
test this hypothesis, Maxi-K channel currents were analyzed in smooth muscle
cells and in AD-293 cells expressing α or α + β1 subunits.
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Methods
Smooth muscle cells. Three coronary artery smooth muscle preparations
were used; these include cells: a) freshly isolated from the canine left anterior
descending (LAD) artery; b) cultured from the canine LAD; and c) cultured from
human hearts. Canine LAD arteries were collected from dogs euthanized under
surgical anesthesia for unrelated experiments. Protocols were approved and
followed guidelines set forth in the Guide for the Care and Use of Laboratory
Animals (National Academy Press, 1996). LAD segments were incubated for 30
min at 37 °C in 20 units ml-1 papain in low Ca2+ HEPES buffer containing (mM)
135 NaCl, 5 KCl, 0.36 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH
7.4. After washing, tissue was incubated for another 30 min at 37 °C in low Ca2+
HEPES buffer containing (mg ml-1) 2 type II collagenase and 1 hyaluronidase.
The solution was gently agitated with a fire-polished Pasteur pipette to disperse
single cells. This suspension was filtered through 100 µm nylon mesh and
centrifuged at 600 g for 5 min. For patch clamp recordings, the pellet was
resuspended with low Ca2+ HEPES buffer and kept at 4 °C. Patch-clamp
recordings were performed within 8 h of cell dispersion. For primary cell culture,
solutions mentioned above also contained 100 units ml-1 penicillin and 100 mg
ml-1 streptomycin and the pellet was resuspended in Medium 231 with smooth
muscle growth supplement (Invitrogen). Cells were plated on 1% gelatin-coated
dishes and incubated in a 5% CO2 incubator at 37 °C. Media was replaced once
or twice as cells grew to confluence; after subculturing, the medium was changed
every 2-3 days. To induce differentiation in confluent cultures, growth medium
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was switched to Medium 231 containing smooth muscle differentiation
supplement (Invitrogen), which was replaced every 2-3 days. Human coronary
artery smooth muscle cells (Genlantis) were cultured in Medium 231 with growth
and differentiation supplements, the latter added at ∼80% confluence.
Transient transfection. AD-293 cells (Stratagene) were grown in DMEM
supplemented with 10% FBS, 100 units ml-1 penicillin, and 100 mg ml-1
streptomycin. Antibiotic-free media was added 1 h prior to transfection. Plasmids
encoding bovine KCNMA1 (ENSG00000156113) and KCNMB1
(ENSG00000145936) were kindly provided by Dr. Michael J. Davis (University of
Missouri; (Wu et al., 2008)). A plasmid encoding GFP, pmaxGFP, was purchased
from AMAXA. Cells grown to 50-70% confluence were cotransfected with
plasmids containing GFP and KCNMA1 with or without KCNMB1 using
Lipofectamine LTX with PLUS reagent (Invitrogen). Transfection with GFP
plasmid only was used as a negative control. The optimal molar ratios of
KCNMA1 to KCNMB1 were determined to be >1:3. After incubation with DNAlipid complexes in opti-MEM for 6 h, the medium was changed to DMEM
supplemented with FBS and antibiotic. Current recordings from GFP-positive
cells were performed 1-2 days after transfection.
Electrophysiology. Freshly isolated cells were placed directly in a
recording chamber on an inverted microscope, while cultured cells were plated
on cover glass that was transferred to the recording chamber. The recording
chamber had a volume of 0.2-0.3 ml and solutions were fed by gravity at a rate of
2-3 ml min-1. BPA (Sigma-Aldrich; product number 133027) and penitrem A (MP
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Biomedicals) were dissolved in DMSO and diluted 1:1000 or 1:10,000 for
experiments. For whole-cell recordings, cells were suffused with a solution
containing (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and
5 Tris; pH 7.4. Pipette solution contained (mM) 140 KCl, 1 MgCl2, 1 EGTA, 10
HEPES, and 5 Tris; pH 7.1. The Ca2+ concentration of the pipette solution was
brought to 100 nM by adding 281 µM CaCl2 (http://www.stanford.edu/
~cpatton/maxc.html). GΩ seals were made with heat-polished borosilicate
pipettes (BF150-86; Sutter Instruments) that had tip resistances of 3-5 MΩ. The
cell was ruptured with suction and membrane capacitance determined from the
capacity transient (pClamp 9; Axon Instruments). Series resistance and
capacitance were compensated as much as possible using the amplifier circuitry
(PC-505B; Warner Instruments). In whole-cell records, mean current during the
last 80 ms of the test pulse was measured for analysis. For single channel
recordings, cells were suffused with the 140 mM K+ solution described above and
pipettes had tip resistances of 5-10 MΩ. After forming GΩ seals, patches were
excised for inside-out recordings in symmetrical 140 mM K+. Channel
conductance was determined from peak-to-peak differences in all-points
amplitude histograms; NPo was calculated by dividing the mean current in a trace
by the single channel amplitude. Currents were low pass filtered at 1 kHz and
digitized at 5 kHz.
RT-PCR. Total RNA was extracted using PureLink RNA Mini kit and
PureLink DNase (Invitrogen). One microgram of template was reverse
transcribed with Oligo(dT)20 primers using the SuperScript First-Strand Synthesis
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System (Invitrogen). PCR primers were designed against KCNMA1
(NM_001014797; 5’-GAGGATGCCTCGAATATCA-3’ and 5’-AGCTCG
GGATGTTTAGCAGA-3’; product size 119 bp) and KCNMB1 (NM_004137; 5’GCCGGG AAGACTAAATGATC-3’ and 5’-TGGGAT GTAGGAGCACTG-3’;
product size 357 bp). PCR amplification was performed in 50 µl reactions
containing 1x PCR buffer, 0.2 mM each dNTP, 1.5 mM MgCl2, 0.4 µM each
primer, 1 µl template cDNA, and 2 units Platinum Taq DNA polymerase
(Invitrogen). The protocol included: denature at 94 °C for 2 min, 40 cycles of 94
°C for 15 s, 55 °C for 30 s, and 70 °C for 1 min; the reaction was terminated at 4
°C. As a positive control, human brain cDNA (Ambion) was used. PCR products
were separated by electrophoresis on 2% agarose with ethidium bromide and
images captured using a GeneFlash unit (Syngene).
Statistics. Data are presented as the mean and standard error of n
number of cells or membrane patches. When two values were compared, a
paired t-test was used. When more than two values were compared, one-way
ANOVA was used. Current-voltage relationships were analyzed by two-way
repeated measures ANOVA. Bonferroni post hoc tests followed ANOVA to
determine where differences exist. In all tests, p < 0.05 was considered
significant.
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Results
The patch clamp technique was used to measure K+ current in coronary
smooth muscle cells and determine the effect of BPA on Maxi-K current using
penitrem A, a potent and selective inhibitor of Maxi-K channels (Knaus et al.,
1994). Whole-cell recording revealed prominent Maxi-K current in smooth muscle
cells cultured from the canine LAD coronary artery (Fig. 1A, left). Timedependent current increased sharply at potentials positive to +40 mV and was
“noisy”, indicating channels with a large unitary conductance were responsible.
Current density at +100 mV was 35 ± 12 pA pF-1 (n = 5). Whole-cell current
increased with the application of 10 µM BPA (Fig. 1A, middle; current density at
+100 mV was 64 ± 24 pA pF-1, p < 0.05). The effect of BPA was not voltagedependent. Penitrem A (1 µM) blocked nearly all of the whole-cell current in
smooth muscle cells cultured from the canine LAD coronary artery (Fig. 1A, right;
current density at +100 mV was 3 ± 2 pA pF-1, p < 0.05). In separate experiments
(n = 4) when 1 µM penitrem A was added first, whole-cell current was reduced
and could not be increased by 10 µM BPA (Fig. 1B; current density at +100 mV
was 33 ± 10, 6 ± 3, and 4 ± 2 pA pF-1, for control, with penitrem A, and penitrem
A plus BPA, respectively; p < 0.05). The voltage template used to elicit currents
is shown in Fig. 1C. Group data for both experiments in cultured canine coronary
smooth muscle cells are shown in Figs. 1D and E. Cultured canine coronary
smooth muscle cells were derived from 3 different dogs and a characterization of
the smooth muscle phenotype of these cells is available in the Supplement.
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Excised patch recordings were used to determine the effect of BPA on
Maxi-K channel NPo in smooth muscle cells freshly isolated from the canine LAD
coronary artery. Inside-out recordings were made in symmetrical 140 mM K+ at a
patch potential of +80 mV with free Ca2+ buffered to 100 nM. BPA (10 µM)
increased Maxi-K channel NPo 742 ± 302% (n = 10 cells from 4 dogs; p < 0.05;
Fig. 2A & B). Single channel conductance was not affected by 10 µM BPA (100 ±
3% of control; Fig. 2C).
To determine the role of the β1 subunit in responses to 10 µM BPA,
whole-cell recordings were performed on AD-293 cells transfected with GFP and
α or α + β1 subunits. Cells transfected with GFP only had very small outward
currents (Fig. 3A; current at +100 mV was 0.04 ± 0.01 nA; n = 3). Cells
transfected with Maxi-K α subunits demonstrated large outward currents with fast
activation and little or no inactivation (Fig. 3B). The current and time constant of
activation at +100 mV were 5.4 ± 1.0 nA and 1.0 ± 0.3 ms, respectively (n = 11).
Cells transfected with both Maxi-K α and β1 subunits possessed large outward
currents with slower activation and demonstrated little or no inactivation (Fig.
3C). Current and time constant of activation at +100 mV were 5.0 ± 1.0 nA and
13 ± 7 ms, respectively (n = 7). In cells with Maxi-K channels composed of α
subunits alone, 10 µM BPA did not substantially increase current (Fig. 3D;
current at +100 mV was 101 ± 13% of control). When Maxi-K channels were
composed of α and β1 subunits, 10 µM BPA increased current by 53 ± 12% (Fig.
3E). Penitrem A (1 µM) blocked virtually all Maxi-K current, regardless of whether
channels were composed of α or α + β1 subunits (93 ± 4 and 93 ± 2% inhibition,
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respectively). Group data illustrating the effects of BPA and penitrem A on MaxiK channels composed of α or α + β1 subunits are shown in Fig. 3F & G.
Inside-out patch recordings were made to determine the effect of 10 µM
BPA on Maxi-K channels composed of α or α + β1 subunits in AD-293 cells. NPo
and single channel conductance were determined at a patch potential of +40 mV
in solutions containing 140 mM K+ and 100 nM free Ca2+. BPA had no significant
effect on NPo or single channel conductance in Maxi-K channels composed of α
subunits alone (Fig. 4A & C). NPo was 123 ± 20% of control in the presence of 10
µM BPA (Table 1; n = 6; p = N.S.). In contrast, in Maxi-K channels containing the
β1 subunit, 10 µM BPA increased NPo (Fig. 4B & D). BPA increased the NPo of
Maxi-K channels containing the β1 subunit 204 ± 41% (Table 1; n = 6, p < 0.05).
BPA had no effect on conductance in channels composed of α or α + β1 subunits
(99 ± 1 and 103 ± 2% of control, respectively).
Experiments were performed on α and α + β1 Maxi-K channels in AD-293
cells to determine whether the effects of BPA were concentration-dependent and
reversible. The response to BPA depended upon the molecular composition of
Maxi-K channels (Fig. 5A). When Maxi-K channels contained the β1 subunit, 1,
10, and 100 µM BPA increased current. This was sharply different from the
response of Maxi-K channels composed of α subunits alone, where neither 1 nor
10 µM BPA significantly increased current. Surprisingly, however, at a
concentration of 100 µM, BPA increased significantly the current in AD-293 cells
expressing only the α subunit. The effect of BPA to increase whole-cell Maxi-K
current was rapid and readily reversible (Fig. 5B). Current through channels
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composed of α + β1 subunits increased dramatically during exposure to 10 µM
BPA (from 4.5 ± 0.4 to 5.6 ± 0.6 nA; p < 0.05, n = 4). In cells expressing α
subunits only, 10 µM BPA modestly increased current from 4.4 ± 0.3 to 4.6 ± 0.1
nA (n = 4). There was no difference in the time course for the onset of BPA effect
between cells expressing α or α + β1 subunits (time constants of 2.0 ± 0.1 vs. 2.1
± 0.1 min) (Fig. 5C). Washing the cells with BPA-free solution rapidly returned
current towards baseline.
Whole-cell patch clamp experiments were also performed on cultured
human coronary smooth muscle cells (Fig. 6). The smooth muscle phenotype of
these cells is demonstrated in the Supplement. The lower concentrations of BPA
(1 and 10 µM) did not increase Maxi-K current; however, 100 µM BPA increased
current significantly (Fig. 6B). Maxi-K current at +100 mV under control
conditions was 843 ± 218 pA and increased to 1446 ± 393 pA with application of
100 µM BPA (n = 6; p < 0.05). Based on concentration-response results with
BPA in AD-293 cells expressing α or α + β1 subunits (Fig. 5), we investigated
whether cultured human coronary smooth muscle cells expressed the β1 subunit.
Thus, RT-PCR was used to analyze Maxi-K channel subunit mRNA expression.
Cultured human coronary smooth muscle cells expressed KCNMA1 mRNA, but
mRNA for KCNMB1 was undetectable (Fig. 6C). A positive control, using human
brain cDNA, however, demonstrated the applicability of the KCNMB1 primers
(Fig. 6C). Moreover, Western blots and immunocytochemistry experiments also
failed to detect the β1 subunit in these cells (data not shown). Thus, the
activation of Maxi-K channels in cultured human coronary smooth muscle cells
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by a minimum concentration of 100 µM BPA is likely due to a lack of KCNMB1
expression (Yang et al., 2009).
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Discussion
These studies demonstrate that BPA, an estrogenic endocrine disruptor,
increases Maxi-K channel current via a nongenomic mechanism. The activation
of Maxi-K channels by BPA depends, in a concentration-dependent manner, on
the presence of the regulatory β1 subunit. Several lines of evidence support
these novel observations. First, BPA-induced activation of Maxi-K channels was
observed in freshly isolated and cultured coronary smooth muscle cells, as well
as in AD-293 cells expressing cloned Maxi-K channel subunits. Furthermore,
BPA increased Maxi-K channel NPo without affecting single channel
conductance. Second, BPA-induced Maxi-K channel activation was detected in
both whole-cell and single channel experiments. Moreover, results of the single
channel studies clearly indicate that the effect of BPA is non-genomic, as the
inside-out patches of membrane were removed from the cell. Third, the effects of
BPA were rapid, reversible, and concentration-dependent. While we
hypothesized that BPA activation of Maxi-K channels would depend on the
presence of the regulatory β1 subunit, this prediction was upheld only partially by
our studies. Specifically, the β1 subunit played a compulsory role in activation of
Maxi-K channels by BPA when concentrations of 1 and 10 µM were tested;
however, at a concentration of 100 µM, BPA activated Maxi-K channels without
the β1 subunit. The latter finding suggests that the α subunit itself might be the
target of BPA and that the β1 subunit simply enhances the response. The
activating effect of BPA on Maxi-K channels and the transformative influence of
the β1 subunit represent original observations of multifaceted mechanisms that
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merit additional study. Because of the potential public health impact of BPA
exposure and the fact that so many cell types express Maxi-K channels, the
implications of these studies may be widespread.
Previous studies document the activation of Maxi-K channels by
estrogenic substances, including 17β-estradiol (Valverde et al., 1999). Thus, to
find that BPA activates Maxi-K channels may not seem surprising at first glance.
However, the lack of a relationship between the estrogenic nature of a compound
and its effect on Maxi-K channels makes such presumptions difficult. For
example, tamoxifen, an estrogen receptor modulator with mixed agonist and
antagonist properties, activates Maxi-K channels more potently and efficaciously
than 17β-estradiol (Dick et al., 2001). Moreover, the pure anti-estrogen ICI
182,780 also activates Maxi-K channels (Dick, 2002). Studies generally agree,
however, that the β1 subunit confers sensitivity upon Maxi-K channels to
estrogens and xenoestrogens (Valverde et al., 1999; Dick et al., 2001; Dick &
Sanders, 2001). Other steroid hormones, including androgens, also activate
Maxi-K channels (Deenadayalu et al., 2001; Han et al., 2008). The role of Maxi-K
channel β subunits, of which there are 4 known types, differs depending upon the
agonist. For example, the β1 subunit is important for Maxi-K channel activation
by 17β-estradiol (Valverde et al., 1999), while β2 and β4 subunits are important
for responses to and discriminate between dehydroepiandrosterone and
corticosterone (a stress-related adrenal androgen and a glucocorticoid,
respectively) (Lovell et al., 2004; King et al., 2006).
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It is clear that xenoestrogens impact not only the interaction of 17βestradiol with nuclear receptors (Krishnan et al., 1993; Kuiper et al., 1997), but
also initiate nongenomic signaling mechanisms. For instance, BPA increases
intracellular Ca2+ in GH3/B6 pituitary tumor cells (Watson et al., 2005; Wozniak et
al., 2005; Watson et al., 2007) and pancreatic β cells (Alonso-Magdalena et al.,
2005). Elevated intracellular Ca2+ could explain the ability of BPA to activate
Maxi-K channels; however, experiments in excised patches with solutions
clamped to a known Ca2+ concentration eliminate the possibility of this
mechanism in the present study. Additionally, while BPA activates signaling by
protein kinases A and G in JKT-1 tesicular seminoma cells (Bouskine et al.,
2009) and these kinases are linked to Maxi-K channel activation (Kume et al.,
1989; Robertson et al., 1993), these mechanisms seem unlikely to explain our
results. This is because ATP and other cofactors necessary for kinase signaling
were absent in the excised patch studies.
Thus, questions remain as to what mechanism(s) underlies the activation
of Maxi-K channels by BPA. The same general uncertainty exists across the field
for activation of Maxi-K channels by steroid hormones and their mimetics. At
present, two types of data support the idea that an extracellular site of the β1
subunit comprises at least a part of the binding domain for these compounds.
First, membrane-impermeable conjugates of estrogen (Valverde et al., 1999) and
tamoxifen (Dick et al., 2002) activate Maxi-K channels containing the β1 subunit
from the extracellular, but not the intracellular, side of the membrane. Second, a
putative binding site for steroid functional groups has been identified in the β1
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subunit (Bukiya et al., 2007; Bukiya et al., 2008a; Bukiya et al., 2008b). Bukiya
and colleagues show that lithocholate, a bile acid formed from cholesterol,
activates Maxi-K channels containing β1, but not β4, subunits. Using a series of
chimeric β1-β4 subunits, they demonstrate a region of the second
transmembrane segment of the β1 subunit that may be particularly important for
binding steroids. β1 subunits, however, are unlikely to be completely responsible
for Maxi-K channel responses to steroids and xenoestrogens. Our data
demonstrating differential BPA sensitivity of α or α + β1 Maxi-K channels support
this concept. It seems possible that the α subunit could be the target of BPA and
β1 subunits enhance BPA binding to the α subunit. In support of this idea,
Korovkina and coworkers have demonstrated that the Maxi-K channel α subunit
itself functions as a binding site for 17β-estradiol, and that β1 subunits enhance
binding by approximately three-fold (Korovkina et al., 2004). Assuming that BPA
may bind to the same site, their observations may explain why the β1 subunit,
while not requisite for BPA-induced activation, increased the BPA-sensitivity of
Maxi-K channels. The idea that the α subunit may be the target of BPA is further
supported by the study of Perez suggesting that the tamoxifen binding site is
located on the Maxi-K α subunit and that β1 subunits facilitate or stabilize the
interaction (Perez, 2005). The possibility remains, however, that BPA interacts
with an unknown molecule to transmit a nongenomic signal that activates Maxi-K
channels. Further experiments are necessary to clarify the molecular
mechanism(s) of BPA induced Maxi-K channel activation.
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An important concern is relevance of the present findings in light of the
levels of BPA exposure, and thus the concentrations of BPA measured, in
humans. Worldwide, annual BPA production exceeds 6 billion pounds and
hundreds of tons of BPA enter the atmosphere. Thus, it is surprising that data
regarding BPA exposure levels remain scarce. Free unconjugated BPA in human
serum ranges from approximately 0.9-90 nM (Vandenberg et al., 2007). Because
free BPA is a minor fraction (5%) of the total BPA load (Csanady et al., 2002),
total serum concentrations are estimated to be 0.017-1.7 µM. Nonetheless, BPA
became a public health concern relatively recently and many controversies exist
about routes of exposure, how much we are exposed to, mechanisms of BPA
action, and associations with disease (Vandenberg et al., 2009). Our data
obtained with micromolar concentrations of BPA appear to be higher than what
most humans are exposed to; however, certain occupational populations are at
much higher risk (Hanaoka et al., 2002). Much remains to be resolved about
human exposure to BPA and its effects; however, we present the first evidence
demonstrating that BPA affects ion channel function directly.
In conclusion, we demonstrate that BPA activates Maxi-K channels in a
nongenomic manner. This study focused on immediate effects of BPA on Maxi-K
channel activity; however, further investigation will be required to determine any
long-term effects of BPA exposure on ion channel function and expression. Our
data indicate that the β1 subunit increases the BPA-sensitivity of Maxi-K
channels; however, the α subunit alone is sufficient for the response of Maxi-K
channels to BPA. The toxicology of BPA is not clear, but in cells that express
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Maxi-K channels, activation by BPA would be expected to hyperpolarize the
membrane potential. This would decrease excitability in cells that express other
voltage-dependent ion channels; however, a more negative membrane potential
would also increase the driving force for Ca2+ entry through open Ca2+ channels.
Based on the present findings, it would be reasonable to suggest that BPA might
act as a vasodilator through the opening of Maxi-K channels. Our findings
represent the first known effects of BPA on an ion channel, but other types of ion
channels should be studied to increase our understanding of BPA toxicity.
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Figure legends
Fig. 1 BPA increases Maxi-K current in smooth muscle cells cultured from
the canine coronary artery. (Panel A) Representative currents are shown under
control conditions, with the application of 10 µM BPA, and with 1 µM penitrem A.
(Panel B) Currents from a representative cell are shown under control conditions,
with 1 µM penitrem A, and with 10 µM BPA in the continued presence of
penitrem A. (Panel C) The voltage template used to elicit currents in this and
subsequent figures. (Panel D) Group data (n = 5) demonstrate the BPA- and
penitrem A-sensitivity of currents in cultured coronary artery smooth muscle cells.
(Panel E) Penitrem A prevented BPA-induced increase in Maxi-K current (n = 4).
Asterisks indicate p < 0.05 vs. control by one-way ANOVA.

Fig. 2 BPA increases Maxi-K channel NPo in smooth muscle cells freshly
isolated from the canine coronary artery. (Panel A) Representative 1 min
recordings of Maxi-K channel activity in an inside-out patch before and after
exposure to 10 µM BPA are shown. Patch potential was +80 mV and currents
were recorded in symmetrical 140 mM K+ with 100 nM free Ca2+. BPA increased
NPo, but had no effect on single channel amplitude. (Panel B) Group data (n = 10
cells from 4 dogs) demonstrate that 10 µM BPA increases NPo. Asterisk indicates
p < 0.05 by paired t test. (Panel C) Group data (n = 10) show that BPA has no
effect on single conductance.
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Fig. 3 Maxi-K β1 subunit confers sensitivity to 10 µM BPA. Currents were
measured from AD-293 cells transfected with GFP (Panel A) and Maxi-K
channels composed of α (Panel B) or α + β1 (Panel C) subunits. Voltage
template used is shown in Fig. 1C. Very little whole-cell current was observed in
cells expressing GFP only. Cells transfected with the α subunit demonstrate large
outward currents with fast activation and little or no inactivation. Cells expressing
α + β1 subunits demonstrate large outward currents with slower activation.
(Panel D) Records from a representative cell transfected with the Maxi-K a
subunit show that current is unaffected by 10 µM BPA, but blocked by 1 µM
penitrem A. (Panel E) Current in a cell transfected with α + β1 subunits increased
with application of 10 µM BPA and was blocked by 1 µM penitrem A. (Panels F &
G) Group data illustrate the effect of 10 µM BPA and 1 µM penitrem A on current
in cells expressing α (n = 11) or α + β1 (n = 7) subunits. Asterisks indicate p <
0.05 vs. control by two-way repeated measures ANOVA.

Fig. 4 BPA (10 µM) increases NPo of Maxi-K channels containing the β1
subunit. Representative 1 s recordings of Maxi-K channel activity in inside-out
patches from AD-293 cells expressing Maxi-K α (Panel A) or α + β1 (Panel B)
subunits before and after exposure to 10 µM BPA. Patch potential was +40mV in
symmetrical 140 mM K+ solutions containing 100 nM free Ca2+. (Panels C & D)
contain all-points amplitude histograms from 1 min recordings of patches shown
in Panels A & B. BPA increased the NPo of Maxi-K channels containing the β1
subunit and no effect on single channel conductance.
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Fig. 5 The activation of Maxi-K channels by BPA is concentrationdependent and reversible. (Panel A) Maxi-K currents were measured in the
whole-cell configuration after stepping membrane potential from -80 to +100 mV.
Cells expressing Maxi-K channels composed of α or α + β1 subunits were
studied (n = 7-12) under control conditions and after exposure to 1, 10, and 100
µM BPA. Current was increased relative to control at all three concentrations in
cells expressing α + β1 subunits; current was increased only with 100 µM BPA in
cells expressing the α subunit alone. Asterisks indicate differences between α
and α + β1 by two-way ANOVA. (Panel B) Maxi-K (α) and Maxi-K (α + β1)
currents were elicited by stepping the membrane potential from -80 to +100 mV
for 300 ms every 10 s. BPA (10 µM) was applied for 2 min and washed out.
Current increased rapidly with exposure to BPA and returned towards baseline
with washout (n = 4). (Panel C) Time course for the activation and the
reversibility was normalized to the maximal activation of each value.

Fig. 6 BPA, at a concentration of 100 µM, increases Maxi-K current in
human coronary artery smooth muscle cells. (Panel A) Representative
records demonstrate that BPA (100 µM) increased whole-cell current in smooth
muscle cells cultured from human coronary arteries. (Panel B) contains group
data (n = 3-7) for effect of three concentrations of BPA on Maxi-K current. (Panel
C) RT-PCR revealed the expression of KCNMA1 (α subunit; 119 bp product) but
not KCNMB1 (β1 subunit; 357 bp product) in cultured human smooth muscle
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cells. Human brain cDNA was used as a control and the expression of KCNMA1
and KCNMB1 was detected. –RT is a reaction without reverse transcriptase;
NTC is a no template control.
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Table 3 1 β1 subunit determines the response of Maxi-K channels to 10 µM
BPA
Subunit(s)
Condition
NPo
Conductance (pS)
α (n = 6)

α + β1 (n = 6)

Control

0.75 ± 0.27

248 ± 8

BPA

1.06 ± 0.42

246 ± 9

Control

0.96 ± 0.11

253 ± 15

BPA

2.97 ± 0.58 (p <

260 ± 13

0.05)
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Figure 3 1 BPA increases Maxi-K current in smooth muscle cells cultured
from the canine coronary artery.
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Figure 3 2 BPA increases Maxi-K channel NPo in smooth muscle cells
freshly isolated from the canine coronary artery
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Figure 3 3 Maxi-K β1 subunit confers sensitivity to 10 µM BPA
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Figure 3 4 BPA (10 µM) increases NPo of Maxi-K channels containing the β1
subunit
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Figure 3 5 The activation of Maxi-K channels by BPA is concentrationdependent and reversible.
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Figure 3 6 BPA, at a concentration of 100 µM, increases Maxi-K current in
human coronary artery smooth muscle cells
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Supplemental information
Cells from the canine coronary artery were cultured and differentiated into
smooth muscle. Cells took ~4-5 days to start effectively dividing and grew to
confluence in ~7 days. Cells no longer grew after passage ~10. Confluent cells
exhibited a “hill and valley” pattern under phase contrast (Supplemental Fig. 1A).
Immunoblots indicated the expression of smooth muscle-specific a actin and
myosin heavy chain in differentiated cells (Supplemental Fig. 1B). Phase contrast
images and smooth muscle-specific a actin and myosin heavy chain
immunoreactivity for cultured human smooth muscle cells are also shown in
Supplemental Figs. 1A & B. Smooth muscle cells were trypsinized and plated on
cover glass for patch clamp experiments. These cells retained the smooth
muscle phenotype, as shown by immunocytochemistry for smooth musclespecific α actin (Supplemental Fig. 2A). After treatment with differentiation media
for 1 or 2 weeks, 75 ± 4 and 90 ± 3% of the canine cells retained the smooth
muscle phenotype (n = 3, Supplemental Fig. 2B). Immunocytochemistry and the
percent of cells with a smooth muscle phenotype are also shown in
Supplemental Figs. 2A & B. Thus, canine coronary artery smooth muscle cells
demonstrated morphology and immunoreactivity consistent with those observed
by others in various species (Teng et al., 2006; Christen et al., 199. Taken
together, we conclude that the majority of cultured cells possessed a smooth
muscle phenotype and were appropriate for study.

METHODS
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Western blots. Cultured cells were washed two times with PBS and
harvested in RIPA lysis buffer supplemented with (mM) 2 PMSF, 1 Na3VO4, 1
DTT and 1x protease inhibitor cocktail solution (Santa Cruz Biotechnology).
Samples were sonicated on ice, incubated for 15 min on ice, and centrifuged at
10,000 g at 4 °C for 10 min. The supernatant was removed and stored at -80°C
until use. Protein concentrations were determined by BCA method using BSA as
a standard (Pierce). Samples were diluted to 1 mg/ml in Laemmli sample buffer
and boiled at 70 °C for 15 min. Equivalent amounts of protein were separated by
SDS-PAGE, followed by electroblotting onto nitrocellulose membranes.
Membranes were blocked with 5% nonfat milk (Bio-Rad) in TBST for 1 h at room
temperature, washed 3 times in TBST, and incubated overnight at 4 °C in
primary antibodies against smooth muscle α actin (1:500; Sigma), smooth
muscle myosin heavy chain (1:500; Biomedical Technologies) and b tubulin
(1:1000; Santa Cruz Biotechnology). After washing 3 times in TBST, membranes
were incubated with anti-species secondary antibody conjugated with HRP and
HRP-linked anti-biotin secondary antibodies for a biotinlyated ladder (1:5000;
Cell Signaling Technology) for 1 h at room temperature and then washed again 3
times with TBST. An enhanced chemiluminescence detection system (ECL
Advance, Amersham Biosciences) was used to detect the antibodies and the
lanes were analyzed using a G:Box system (Syngene).
Immunocytochemistry. Differentiated cells were plated on cover glass and
allowed to adhere overnight. Cells were washed with PBS and fixed in 4%
formaldehyde in PBS, pH 7.4 for 30 min at room temperature. After three washes
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in PBS, cells were permeabilized with 0.1% Triton X-100 in PBS for 2 min. Cells
were treated 30 min in blocking solution (2% goat serum, 3% BSA in PBS) and
then incubated with anti-smooth muscle-specific α actin (1:400; Sigma) for 1 h at
room temperature in a humidified chamber. Following three washes with PBS,
cells were incubated with Alexa Fluor 488-conjugated anti-mouse IgG (1:1000;
Invitrogen) for 1 h at room temperature in a humidified chamber. After a final
wash with PBS, cover glass was placed on mounting medium (Santa Cruz
Biotechnology) on a slide. Images were obtained with an epifluorescence
microscope and a SPOT RT camera (Diagnostic Instruments).
REFERENCES
Teng, B, Ansari, HR, Oldenburg, PJ, Schnermann, J, Mustafa SJ. (2006)
Isolation and characterization of coronary endothelial and smooth muscle cells
from A1 adenosine receptor knockout mice. Am J Physiol Heart Circ Physiol.
290(4):H1713-1720.

Christen, T, Bochaton-Piallat, ML, Neuville, P, Rensen, S, Redard, M, van Eys,
G, Gabbiani, G.
(1999) Cultured porcine coronary artery smooth muscle cells. A new model with
advanced differentiation. Circ Res 85: 99-107.
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Supplemental Fig. 1 Cells cultured from the canine LAD coronary artery
revealed typical smooth muscle morphology and expressed smooth
muscle phenotypic markers. (Panel A) Phase contrast images of cells cultured
from the canine coronary artery develop over time into a characteristic “hill and
valley” morphology. Human smooth muscle cell cultures are also shown. (Panel
B) Immunoblot of smooth muscle-specific myosin heavy chain and α actin in
canine and human cells. The expression of these smooth muscle markers
increased over time in differentiation media.

Supplemental Fig. 2 Smooth muscle cells plated for patch clamp
experiments continue to express phenotypic markers. (Panel A)
Immunofluorescence of smooth muscle-specific α actin (green) during
differentiation; nuclei are stained blue. Images from canine and human cells are
shown. (Panel B) The percentage of cells in culture that express smooth musclespecific α actin increases over time in differentiation medium (n = 3). Asterisks
indicate p < 0.05 vs. day 0.
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Figure 3 7 Supplemental Figure 1. Cells cultured from the canine LAD
coronary artery revealed typical smooth muscle morphology and
expressed smooth muscle phenotypic markers
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Abstract
Background and purpose: Bisphenol A (BPA) is an estrogenic endocrine
disruptor implicated in the development cardiovascular disease. We previously
demonstrated that BPA activates smooth muscle BK (KCa1.1) channels nongenomically (Asano et al. Br J Pharmacol. 160(1):160-70, 2010). This finding is
seemingly inconsistent with BPA-induced cardiovascular disease. Importantly,
however, estrogen also activates BK channels, but negatively regulates
KCNMA1, the gene encoding BK channels. It is possible that BPA might have a
similar effect; therefore, we tested the hypothesis that BPA reduces BK channel
expression though a genomic mechanism.
Experimental approach: Rat aortae were placed in tissue culture for a 48-72
hour treatment with BPA (10 µmol/L). BK channel expression was determined by
RT-PCR, Western blot, and whole-cell patch clamp. Experiments repeated with
BPA in the presence of ICI 182,780 (1 µmol/L), an estrogen receptor antagonist.
Key Results: BPA decreased the expression of BK α subunit mRNA and protein.
Penitrem A-sensitive BK current was reduced in smooth muscle cells from BPAtreated aortae. ICI 182,780, an estrogen receptor antagonist, blocked the effect
of BPA to reduce BK channel mRNA, protein, and current.
Conclusions and implications: These data indicate BPA decreases BK
channel expression via activation of nuclear estrogen receptors. Further, our
findings represent one potential mechanism by which BPA exposure may
possibly be linked to cardiovascular disease.
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Introduction
Bisphenol A (BPA) is used to manufacture polycarbonate plastic, resin
lining of cans, and dental sealants. Further, BPA is used as a non-polymer
additive to other plastics. A number of recent studies support the idea that BPA
may be associated with carcinogenesis, altered reproductive function, and
developmental issues due to its estrogen mimetic properties (Wetherill et al.,
2005; Savabieasfahani et al., 2006; Vandenberg et al., 2007; Hugo et al., 2008).
Thus, the FDA has some concerns regarding the effect of BPA, particularly in
susceptible populations, such as fetuses, infants, and children. Recent
epidemiological studies have revealed a significant relationship between urinary
BPA concentration and cardiovascular diseases in the American adult population
(Lang et al., 2008; Melzer et al., 2010). Furthermore, there is an association
between erectile dysfunction and urinary BPA concentration in BPA-exposed
workers (Li et al., 2010a; Li et al., 2010b). These studies suggest BPA-related
pathologies may affect a much greater population, and altered vascular function
with BPA exposure could be suspected, nonetheless; the mechanism of BPA
action in vasculature remains unclear.
We demonstrated that acute BPA exposure could activate large
conductance, voltage/Ca2+-sensitive K+ (BK; KCa1.1) channels in vascular smooth
muscle via a non-genomic mechanism (Asano et al., 2010). This non-genomic
effect of BPA on BK channels was similar to that of estrogen and tamoxifen
(Valverde et al., 1999; Dick et al., 2001). Estrogen has relevant genomic
mechanisms as well, as it alters K+ channel expression in variety of tissues (Drici
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et al., 1996; Roepke et al., 2007; Saito et al., 2009). BK channel expression in
uterine smooth muscle was decreased in late pregnancy, when estrogen is
highest (Song et al., 1999). Furthermore, long-term exposure to estrogen has
been shown to directly interact with BK channels and down regulate BK channel
expression in a heterologous expression system and human coronary artery
smooth muscle (Korovkina et al., 2004). These studies demonstrate that BK
channel is an estrogen-sensitive protein and it may be associated with BPArelated cardiovascular pathologies. However, the effect of continuous exposure
to BPA on functional BK channel expression vascular smooth muscle cells is not
known. Therefore, this study examined whether BPA modulates BK channel
expression in vascular smooth muscle cells and sought to determine the
mechanisms. We hypothesized that BPA would alter BK channel expression
through a mechanism that is dependent on interaction with classical estrogen
receptors. To test this hypothesis, functional BK channel expression was
analyzed in A7r5 cell lines and rat aorta.
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Methods
Cell culture. A7r5 cells were purchased from American Type Cell Culture
Collection (ATCC) and were cultured in DMEM supplemented with antibiotic (100
U/ml penicillin G, 100 µg/ml streptomycin) and 10% fetal bovine serum. Cells
were maintained at 37°C and 5% CO2 in a humidified incubator. The growth
medium was replaced with phenol free DMEM (Invitrogen) supplemented
antibiotic (100 U/ml penicillin G, 100 µg/ml streptomycin) and 10% fetal bovine
serum.
Tissue preparation and culture. The method previously described to
culture arteries was utilized (Kleppisch et al., 1996). Briefly, aortae were collected
from male Sprague Dawley rats (age 9-12 weeks) euthanized following unrelated
experiments. Thoracic aorta was dissected and opened along its longitudinal axis
in in low Ca2+ HEPES buffer containing (mM) 135 NaCl, 5 KCl, 0.36 CaCl2, 1
MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. The aorta was cleaned of
adventitia under the dissecting microscope and endothelial cells were removed
by rubbing the lumen with cotton swab. After cleaning the tissue, aorta was cut
into 3 pieces. These pieces of aortae were randomly placed in 35 mm dishes
filled with phenol-free DMEM supplement with 0.5% BSA and antibiotics (100
U/ml penicillin G, 100 ug/ml streptomycin). Cultured aortae were treated with
0.1% DMSO, 10 µM BPA, and 10 µM BPA + 100 nM ICI 182780 for 2 days for
mRNA expression assessment and for 3-4 days for protein function/expression.
BPA (Sigma-Aldrich), estradiol (MP Biomedicals) and ICI 182,780 (SigmaAldrich) were dissolved in DMSO and diluted 1:1000 for experiments.
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Electrophysiology. Whole-cell patch clamp recordings were performed
on single smooth muscle cells isolated from cultured rat aorta as described
previously. In brief, solutions used in the recording conditions were a bath
solution containing (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10
HEPES, and 5 Tris; pH 7.4. Pipette solution contained (mM) 140 KCl, 1 MgCl2, 1
EGTA, 10 HEPES, 1 ATP, 0.1 GTP and 5 Tris and free Ca2+ 100 nM; pH 7.1.
After the successful whole-cell configuration, ramp recordings from -100 to +100
mV were performed until steady state whole-cell currents were observed.
Immunoblotting, Western blot was performed using anti-ER alpha
(1:250; NeoMarker RM-9101), ER beta (1:250; abcam ab3577), and BK channel
α subunit (1:500; alomone lab) antibodies. The details of procedures were
described previously (Asano et al., 2010). Rat ovary was used for the positive
control for ERs in the western blot. For BK α subunits positive control, HEK cells
were transfected with a plasmid encoding hSlo αβ1 (kindly provided by Dr.
Lippiat from University Leeds) and these cell lysates were used as positive
control.
Reverse transcriptase polymerase chain reaction (RT-PCR). RT-PCR
was performed as described previously (Asano et al., 2010). Details of primers
and PCR condition are described in Table 1.
Data Analysis. Results are presented as mean ± SEM. Data were
analyzed using Prism software (GraphPad; San Diego, CA). Significant level was
set at p<0.05.
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Results
Estrogen receptors in rat aorta. The mRNA and protein expression of
ERs have been identified in varied types of vascular smooth muscle cells
including different vascular beds, cultured, and species (Orimo et al., 1993;
Karas et al., 1994; Freay et al., 1997). However, expression in our models (A7r5
cells and cultured rat aorta) is unknown. We performed RT-PCR to conform ER
expression in A7r5 cells and cultured rat aorta (Fig.1 A&C). Interestingly, different
degree of expression of ER α and β were observed in A7r5 cell and cultured rat
aorta. In order to further confirm the ER expression in our study model, we
examined protein expression level by immunoblotting (Fig 1 B&D). Using rat
ovary as a positive control, anti ER α antibody (NeoMarker RM-9101) detected
an immunoreactive band around 64 kDa in A7r5 and cultured rat aorta. Similarly,
anti ER β antibody (abcam ab3577) detected a prominent band around 52 kDa in
these cells. These findings were consistent with other studies utilizing
pharmacological approach to identify ERs in vascular smooth muscle cells
(Bolego et al., 2005). Our RT-PCR and Western blot data indicated that A7r5 cell
and cultured rat aorta express both ERα and β.
Effect of BPA on BK channel expression. E2 has been shown to alter
mRNA expression of BK channel α subunits (Song et al., 1999; Benkusky et al.,
2000; Eghbali et al., 2003; Jamali et al., 2003). RT-PCR data showed BPA
altered BK channel α subunits mRNA levels in A7r5 cells (Fig2 A). To determine
whether BPA altered the expression of BK channel α subunit protein content in
rat vascular smooth muscle cells, immunoblot using Anti-BK channel α subunit
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was performed. Using HEK cells overexpressed human BK αβ1 subunit as
positive control, a prominent band around 125 kDa was observed in cultured rat
aorta (Fig 2 A). Group data (n=7) indicated that BK α subunits content was
reduced to 33.3 ± 7.9% of control in BPA-treated aortae (p<0.05). We tried
several different anti- BK β1 subunits antibodies to examine whether BK β1
subunit expression was similarly reduced by BPA, however, those commercially
available anti BK β1 subunits antibodies could not detect endogenous level of BK
β1 subunits expression (data not shown). Taken together, BPA decreased BK α
subunit protein expression in rat aorta.
ER antagonist prevents BPA-induced reduction in BK channel
expression. In order to further examine the effect of BPA on the functional
expression of BK channels, whole cell patch clamp recording were performed on
vascular smooth muscle cells. Whole cell recordings from cultured rat aortic
smooth muscle cells showed voltage dependent outward rectifying currents (Fig.
3). Compared to aortic SMC treated with vehicle, whole cell current densities at
100 mV were 57.2 ± 6.5 % lower in aortic SMC treated with 10 µM BPA (n=9
from 3 different rats, p< 0.05) while whole cell current densities at 100 mV from
aortic SMC treated with BPA + ICI were not different. (100.7 ± 13.9 % of control,
n=14 from 5 different rats). Penitrem A (1 µM), BK channel antagonist, blocked
66.6 ± 6.0 % of outward currents at 100mV in vehicle (0.1% DMSO) treated
aortic SMCs with intracellular Ca2+ 100 nM (n= 9 from 6 different rats, p< 0.05). In
BPA (10 µM) treated aortic SMCs, outward currents were blocked 40.0 ± 13.7 %
by penitrem A (n=4 from 3 different rats, p< 0.05). Outward currents were
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blocked by 68.8 ± 7.7 % by penitrem A from BPA+ ICI (100 nM) treated aortic
SMCs (n=6 from 4 different rats, p< 0.05). Although we detected BK channel
mRNA (Fig. 2 A) and protein (Fig. 2 B) in A7r5 cells and functional BK channel
expression was reported in a previously (Si et al., 2006), we were unable to show
any functional BK channel expression in A7r5 cells (thus no patch clamp data are
shown). To determine the mechanism by which BPA reduced BK channel
expression, we utilized a specific ER antagonist to test our hypothesis that BPA
decreases BK channel expression via a genomic mechanism. Patch clamp whole
cell recording indicated the mean penitrem A sensitive current density at 80 mV
was 30.9 ± 5.61 pA/pF, 22.2 ± 2.47 pA/pF, 45.6 ± 8.29 pA/pF in DMSO, 10 µM
BPA and BPA + 100 nM ICI, respectively (p< 0.05).
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Discussion
The purpose of this study was to examine the effects of long term BPA
exposure on functional BK channel expression in vascular smooth muscle cells.
Major findings of this study were: 1) BPA significantly decreased BK channel
mRNA/protein expression in A7r5 cells and cultured rat aorta; 2) penitrem Asensitive BK channel currents in rat aortic smooth muscle were significantly
diminished by BPA treatment; 3) BPA reduces BK channel expression through a
mechanism depending up classical ER mediated signaling.
The mechanisms by which BPA is associated with cardiovascular
diseases are far beyond our understanding since the association between human
BPA exposure and cardiovascular disease is a relatively recent public health
concern. However, recent studies are attempting to shed light on some of the
potential mechanisms. For instance, BPA in the nanomolar range can promote
cardiac arrhythmias due to increased SR Ca2+ leak via mechanisms depending
on different ERs based on gender (Yan et al., 2011; Belcher et al., 2012).
Additionally, BPA in the micromolar range can alter atrial contractility via NOcGMP mediated mechanisms (Pant et al., 2011). Similarly, previous works by our
laboratory have shown that the acute micromolar range of BPA exposure
activates BK channel in canine and human coronary artery via non-genomic
mechanisms (Asano et al., 2010). Finding that BPA was a BK channel opener did
not readily fit with the idea that BPA is associated with cardiovascular disease;
therefore, we decided to investigate longer exposure. In this study, we
demonstrated 48-72 hr exposure to BPA decreased BK channel expression in
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vascular smooth muscle via ER-mediated signaling. Taken together, these works
may represent some of the possible explanations for the BPA associated altered
vascular function seen in epidemiological studies (Lang et al., 2008; Melzer et al.,
2010; Melzer et al., 2012).
Estrogen/BPA on BK channel expression. The functions of estrogen
are quite complex, in that it is involved not only in classical reproductive function
and cell growth, but also in other systems such as the cardiovascular system.
Particularly, after the results of a long period of trial and error, the current
perspective of hormone replacement therapy (HRT) is that it increases the risk of
cardiovascular diseases. Therefore; HRT is no longer recommended for the
prevention of cardiovascular diseases (Mosca et al., 2001; Rossouw, 2006). The
mechanisms by which HRT increases the risk of cardiovascular diseases are not
fully understood. One possibility may be E2 induced altered ion channel
expression, which has been seen in a number of other studies (Ranki et al.,
2002; Kundu et al., 2007; O'Mahony et al., 2007; Kundu et al., 2008). Of those
we were particularly interested in the BK channel since it plays a crucial role in
vascular function (Nelson et al., 1995).
Currently, there are several possible proposed mechanisms of alteration in
BK channel current density via long-term E2 treatment (and presumably BPA
exposure). One of them is that E2 causes alternative splicing to BK transcripts
that causes fundamental changes to the BK channel’s properties such as Ca2+
and voltage sensitivity. This mechanism is supported by studies from England’s
group showing that E2 and pregnancy induced up-regulation in both mRNA and
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protein expression in mouse uterine smooth muscle cells, but diminished BK
channel currents (Benkusky et al., 2000; Holdiman et al., 2002). In contrast to
these data, a study by Toro and Stefani’s groups demonstrated E2 downregulates both BK channel mRNA and protein expression in rat uterine smooth
muscle (Song et al., 1999). Furthermore, E2 regulates BK channel expression by
different mechanisms depending on the species. Specifically E2 regulates BK
channel surface expression by transcriptional regulation in rat myomerium,
whereas membrane trafficking of BK channel is the major mechanism in
regulation of BK channel surface expression in mice myometrium (Eghbali et al.,
2003). A final proposed mechanism is that the BK channel itself serves as an E2
receptor and that E2 binding to BK channels triggers proteasomal degradation to
decrease BK channel expression in human coronary artery smooth muscle cells
(Korovkina et al., 2004). These data typify the complex effects of E2 on the
regulation of BK channel expression, however, all these studies agree on one
point; that long-term treatment of E2 decreases functional BK channel expression
(Wang et al., 1998; Song et al., 1999; Benkusky et al., 2000; Holdiman et al.,
2002; Eghbali et al., 2003; Korovkina et al., 2004). Assuming BPA may regulate
BK channel expression in the same way as E2 does due to its estrogenic
properties, our results agree with these previous reports that demonstrated
reduced BK channel current density with E2 exposure. Our data showed that the
BPA-induced decreases in BK channel currents were most likely due to
decreased protein expression in rat aorta.

135

It is reasonable to speculate that BPA acts similar to E2, as it is estrogenic;
nevertheless, it is also possible that BPA uses totally different mechanisms that
as of yet, have not been identified. Although our data demonstrate that a pure
estrogen receptor antagonist (ICI 182, 780) reversed the BPA-induced decrease
in BK channel function (suggesting ER-mediated signaling), we cannot rule out
other possibilities such as membrane-initiated estrogen signaling (e.g. GPER
activation) may regulate BK channel expression. BPA may also activate GPER
mediated cell signaling, and addressing these membrane initiated signaling will
require additional experiments. Further studies are needed to determine how
other cell signaling pathways are involved in BPA-induced decreased in BK
channel expression in vascular smooth muscle.

Estrogen up-regulates BK channel function in uterine artery.
In contrast to our data, E2 has been shown to reduce myogenic tone by
mechanisms that depend on the up-regulation of BK β1 subunit, but not in α
subunits in pregnant sheep uterine artery (Nagar et al., 2005; Hu et al., 2011). A
similar study using uterine vascular smooth muscle from ewes showed that E2
increased both BK α and β1 subunits mRNA/protein (Rosenfeld et al., 2009). We
do not have data to explain the controversy, however, expression of BK channels
by E2 is regulated differently in various species (Eghbali et al., 2003).
Furthermore, some authors have mentioned that different mechanisms of BK
channel α or β1 subunits up-regulation exist based on factors as seemingly trivial
as branch orders of uterine arteries. Again, these results highlight the complex
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effects of E2 on BK channel expression. In our experiments, we have tried
several BK β1 subunit antibodies to analyze the β1 subunits expression levels,
however, while those commercially available β1 subunit antibodies were able to
detect overexpressed hSlo β1 and bSlo β1, they were inadequate for detection of
endogenous BK β1 subunit expression. Therefore we do not know the effect of
BPA on BK channel β1 expression in rat aorta. Based on this, it may be possible
that several factors such as different vascular beds, sizes and species play a role
in E2/BPA induced altered BK channel expression.
A link between BPA exposure and BPA associated pathologies. Many
studies have detected BPA in urine, blood and tissue, but the levels of BPA
exposure are controversial. BPA has been shown to accumulate in adipose
tissue (Nunez et al., 2001; Fernandez et al., 2007) so that the local BPA
concentrations could be higher than the values reported in total blood.
Furthermore, cumulative BPA exposure levels may play a role in BPA associated
pathologies. Although these studies make it difficult to assess exact blood BPA
levels, the BPA concentration we used (10 µM) is likely to be applicable to the
occupational BPA exposure studies showing high levels of BPA exposure
(Hanaoka et al., 2002; Li et al., 2010a). Interestingly, there was an over 4-fold
increase in erectile difficulty that may suggest vascular dysfunction in BPA
exposed workers than non-exposed workers (Li et al., 2010a). According to our
findings, BPA-induced decreased functional BK channel expression in vascular
smooth muscle may be the one of plausible mechanisms.
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Although it is beyond the scope of this study, much attention has been
given to the effects of BPA exposure on the development of fetuses, infants and
young children. It has been demonstrated that Drosophilia slowpoke (dSlo;
homologous to human KCNMA1) gene expression is precisely regulated based
on specific cell types and developmental periods for the normal development
(Brenner & Atkinson, 1996; Chang et al., 2000). Whether BPA alters BK channel
expression during development periods is not determined yet. Additional
experiments regarding BPA toxicity on ion channels will add to our understanding
of the link between BPA exposure and BPA associated pathologies.
In summary, we demonstrate that BPA reduces BK channel expression in
vascular smooth muscle. Given that estrogen regulates BK channel expression,
this effect of BPA on BK channel expression is likely to be an estrogenic property
of BPA. The mechanisms by which BPA reduced BK channel expression
involved in classical ERs and nuclear signaling pathways. The findings are novel
because they represent the firs known effects of BPA on ion channel expression
in any tissue. Additional studies designed to examine in vivo effects of BPA on
BK channel expression; as well as to explore other potential ion channel targets
will be necessary to increase our understanding of the clear explanation of the
association of urinary BPA levels and cardiovascular diseases.
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Figure legends
Fig. 1. Cultured rat aorta and A7r5 cells express estrogen receptors. A.B)
mRNA expression levels of ERs from A7r5 cells and cultured aortas were
analyzed by RT-PCR. C,D) Protein expression levels of ERs were determined by
immunoblotting. A rat ovary was used as a positive control for RT-PCR and
Western blot.

Fig. 2. BPA reduces BK channel expression. A) A picture of RT-PCR data
from different doses of BPA treated A7r5 cells. B) Whole cell lysates obtained
from A7r5 cells treated with different doses of BPA were analyzed by
immunoblotting with Anti-BK channel α subunit antibody. Group data normalized
to SM α-actin showed BPA decreased BK channel expression from A7r5 cells in
a concentration-dependent manner (n=8). C). Proteins isolated form cultured rat
aortae were analyzed by immunoblotting with Anti-BK channel α subunit
antibody. Group data indicated 10 µM BPA decreased BK channel expression (n
=7). An asterisk (*) indicates significant difference from vehicle treated sample. P
< 0.05.

Fig. 3. BPA decreases functional BK channel expression in cultured rat
aorta. Functional BK channel expressions from BPA treated cultured aorta were
analyzed by patch clamp whole cell recordings. Currents were elicited by using
the voltage template shown. Penitrem A, a selective BK channel antagonist, was
utilized to identify BK channel currents. A~C) Representative current traces and
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IV relationship from vehicle (0.1% DMSO), 10uM BPA, and 10uM BPA +100nM
ICI (ERs antagonist) treated rat aorta. An asterisk (*) indicates significant
difference from penitrem A (P < 0.05).

Fig. 4. ER antagonist (ICI 182,780) abrogates effect of BPA on BK channel
expression A). Representative penitrem A-sensitive currents from each
treatment. Group data (n=4 each group) from penitrem A sensitive currents
demonstrated BPA significantly decreased BK channel currents and pretreatment
with an ER antagonist prevented BPA induced decreased BK channel
expression. P < 0.05. B). Western blot data indicated BPA decreased BK channel
protein contents and that ICI pretreatment blocked this effect. An asterisk (*)
indicates significant difference from vehicle treated sample. P < 0.05.
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Table 4 1 Primers used for the RT-PCR analysis
mRNA
Forward primer
Reverse Primer

Esr1

5’-

Size (bp)

5’-

190

NM_012689 CATCGATAAGAACCGGAGGA-3’ AAGGTTGGCAGCTCTCATGTExon 4

3’
Exon 5

Esr2

5’-

5’-

NM_012754 TTCCCGGCAGCACCAGTAAC
C-3’

262

TCCCTCTTTGCGTTTGGACTA-3’
Exon 3

Exon 2

KCNMA1
(NM_03182

5’TCGACATGGCTTTCAACGTG3’

5’GTATACAGACACAAACACGGG
G-3’

8)

Exon 13

Exon 14

Actb

5’-

5’-

NM_031144 CCTGAAGTACCCCATTGAACAC GAGTCCATCACAATGCCAGTG
-3’

-3’

142

140

267

Exon 3

Exon 4

Some of these primer sets have previously used by others (Zancan et al.,
1999; Amberg et al., 2003).
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Figure 4 1 Cultured rat aorta and A7r5 cells express estrogen receptors
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Figure 4 2 BPA reduces BK channel expression

145

Figure 4 3 BPA decreases functional BK channel expression in cultured rat
aorta
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Figure 4 4 ER antagonist (ICI 182,780) abrogates effect of BPA on BK
channel expression
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CHAPTER 5 General Discussion
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Conclusion
The purpose of this dissertation was to determine whether BPA modulates
vascular BK channel function and expression. Furthermore, we wanted to
determine the mechanisms of BPA-induced reduction in BK channel function and
expression. Our long-range goal was to identify molecular mechanisms by which
estrogenic chemicals affect vascular function. Our objective was to determine
mechanisms by which BPA modulates BK channel expression and function. The
central hypothesis was that BPA alters BK channel expression and function
through separate genomic and non-genomic mechanisms. The rationale was that
receptors for BPA exist at both the cell membrane and in the nucleus.
Human BPA exposure and cardiovascular disease became public health
concerns relatively recently; furthermore, we do not understand whether a cause
and effect relationship exists in the association of BPA exposure and
cardiovascular diseases seen in epidemiological studies. We chose ion channels
for the possible target protein for the effects of BPA. Specifically, we selected BK
channels as a target molecule since it is expressed in a variety of tissues and
involved in a variety of cellular functions (Ahluwalia et al., 2004; Ruttiger et al.,
2004; Meredith et al., 2006; Pyott et al., 2007; Grimm et al., 2009) and plays an
important role in vascular tone. Since the gold standard BK channel antagonist,
IBTX, has experimental limitations such as cost and membrane impermeability,
we reasoned that the characterization of an economical pharmacological
alternative would facilitate the study of BK channels. Thus, our initial experiments
have systematically characterized the effect of penitrem A, a tremorgenic
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mycotoxin, on BK channels and demonstrate the role of BK channels in the
vascular function of mice (Chapter 2). Our data demonstrated that whole cell
currents from HEK 293 cells transfected with hSlo α or α + β1 were effectively
blocked by penitrem A (IC50 7 vs. 107 nM; p<0.05). The inhibitory effects of
penitrem A (50.4 ± 9.38 %) and IBTX (49.7± 9.44 %) on K+ currents were the
same degree in coronary artery smooth muscle cells. As for specificity, penitrem
A had no effect on Kv1.5 currents and pinacidil-induced vasodilation. Finally, in
vivo hemodynamic response indicated that penitrem A significantly augmented
phenylephrine induced increases in mean arterial blood pressure by blocking BK
channel in mice (p<0.05). Taken together, our data indicated that penitrem A is
an excellent tool to study BK channel in vascular function and is not only practical
for cell/tissue in vitro studies, but also for whole animal in vivo vascular functional
studies.
Next, we wanted to determine the effect of BPA on BK channels using
penitrem A. Our data showed that BPA increased BK channel currents and BK
channel β1 subunits facilitated BK channel’s sensitivity to BPA (Chapter 3). This
was determined by whole cell recording showing greater outward current with
acute BPA exposure in cultured CCASMCs and HCASMCs. Single channel
recording from freshly isolated canine LAD revealed that BPA increased NPo of
BK channel. Based on these findings from cultured cells and freshly isolated
cells, we next performed the patch clamp experiments on BK channels
exogenously expressed on the cells that do not express BK channels
endogenously. In these experiments, cells transected with BK α and β1 subunits
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revealed a significant increase in BK channel current and greater NPo when cells
were exposed to 10 µM BPA. In contrast, cells with BK channel α subunits alone
showed no significant increase in BK outward currents or NPo. Given that
several steroid hormones activate BK channel via β subunits (Valverde et al.,
1999; Lovell et al., 2004; King et al., 2006), it is possible that xenoestrogens also
may be associated with β subunit dependent BK activation. These findings are
important as they should serve as additional evidence that the xenoestrogen,
BPA, activates BK channels and the role of BK β subunits on steroid hormones
and xenoestrogens induced BK activations. Non-genomic effect of BPA on BK
channel is summarized in Fig. 5-1.
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Figure 5 1 Non-genomic effect of BPA on vascular BK channel.
BPA can activate BK channel independent of changing intracellular Ca2+ levels.
BK β1 subunits favors BPA induced BK channel activation.
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The effects of long-term exposure to BPA on BK channel expression were
assessed on A7r5, rat aortic cell lines, and cultured rat aorta. In this part of the
study (Chapter 4), we hypothesized that BPA would decrease BK channel
expression through estrogen receptor dependent signaling. The principle behind
this hypothesis was that BK channel gene expression and functional protein
expression from uterine smooth muscle cells are known to be estrogen-sensitive.
(Wang et al., 1998; Song et al., 1999; Benkusky et al., 2000; Holdiman et al.,
2002; Eghbali et al., 2003; Korovkina et al., 2004). Given that BPA possesses
estrogenic properties, we tested whether BPA altered BK channel expression in
rat aorta. Our data indicated that BPA altered BK channel transcript from A7r5
cells and decreased protein expression levels in A7r5 cells and cultured rat aorta.
The mechanisms of BPA induced decreased BK channel expression depended
on classical estrogen receptor signaling, as confirmed by an estrogen receptor
antagonist that inhibits BPA’s effects on BK channels. Taken together, our data
suggested that long term BPA exposure decreased BK channel expression via
genomic mechanisms. The genomic effect of BPA on vascular BK channel
expression is summarized in Fig. 5-2.
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Figure 5 2 Genomic effect of BPA on vascular BK channel.
BPA can activate BK αβ1 channels at the plasma membrane. Additionally, BPA
can interact with ERs to regulate BK channel α subunit expression. ER
antagonist, ICI 182, 780 can prevent the effect of BPA to reduce BK channel α
subunit expression.
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It is important to mention some limitations of this study. In order to assess
the genomic and nongenomic effects of BPA on the BK channel, multiple model
cells were utilized. Specifically, nongenomic pharmacological properties of BPA
were elucidated using cultured and native vascular smooth muscle cells, as well
as cloned BK channels, including: cultured canine coronary smooth muscle cells,
cultured human coronary artery smooth muscle cells, cloned bovine BK channels
expressed in HEK 293 cells, and native canine coronary artery smooth muscle
cells. The reason we used so many different cell types over time was basically
due to comments from grant and manuscript reviewers (e.g., previous results
were in canine cells, so reviewers asked us to establish a canine cell culture
model). Further, we chose human coronary cells for relevance, but abandoned
the model due to cost. We realize that having this number of model cells can be
distracting; however, similar results from multiple cell types strengthened our
conclusion that BPA activated BK channels through a non-genomic mechanism
depending on the β1 subunit. The genomic effects of BPA on BK channels were
tested in A7r5 cells (a neonatal rat aortic cell line) and smooth muscle from tissue
cultured rat aorta. Given that the expression of BK channel by estrogen is
regulated in different ways based on species, we limited our model system to rats
for the genomic studies. It is possible that the effect of BPA on BK channel
expression may be different in other species. Although our study demonstrate
that BPA decreased BK channel expression via ERs, it is possible that BPA may
utilize other mechanisms in reducing BK channel expression (e.g., proteosomal
degradation). Since the genomic and nongenomic mechanisms of BPA’s effects
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on BK channel were elucidated in different models, a criticism could be that each
mechanism is model-specific. Importantly, however, we demonstrated both
genomic and non-genomic mechanisms of BPA in rat aorta, suggesting that the
results can be generalized to other smooth muscle. Whether both genomic and
non-genomic effects are relevant to human BPA exposure needs to be examined
in future studies.
Given that BPA is detected in over 95 % of the US population and similar
findings have been reported world wide, there is little doubt that some level of
BPA is in virtually everyone's system. One important question that needs to be
addressed is whether the levels of BPA exposure to the general population are
significant for cardiovascular disease. Table 1 was derived from a review study
by Vandenberg LN et al (Vandenberg et al., 2007). The majority of
epidemiological studies indicated geometric mean urinary BPA ranges from
1.12~27.3 ng/ml. Based on these studies, the current consensus regarding
human BPA exposure levels is in the parts per billion levels (vom Saal et al.,
2007). Recent data of urinary BPA levels from US NHANES (2003/2004 and
2005/2006) are also within these ranges (2.6 ug/L (Calafat et al., 2008), 2.49
ng/ml, (Melzer et al., 2010)) and data from the European Prospective
Investigation of Cancer (EPIC) were median urinary BPA 1.3 ng/ml (Melzer et al.,
2012).
Interestingly, there is a BPA pharmacokinetic study on human subjects
that directly measured both blood and urinary BPA levels (Volkel et al., 2002).
The study demonstrated that peak blood d16-BPA-glucuronide was approximately
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6-fold higher than urinary d16-BPA-glucuronide after consuming radiolabeled BPA
(5 mg/person). Furthermore, local BPA concentration could also be higher
because BPA can be stored in adipose tissue and it has been suggested that it
leaches from adipose tissue (Nunez et al., 2001; Fernandez et al., 2007b). Thus,
it is difficult to assess how accurately these urinary BPA levels reflected blood
BPA levels. On the other hand, in factory workers who are exposed BPA
because of their occupation, median urinary BPA concentrations were 84.6 µg/g
Cr (He et al., 2009), 57.9 µg/g Cr (Li et al., 2010) and this population had over
20-30 times more exposure compared to the general population (2.6 µg/g Cr, US
NHANES) (Calafat et al., 2008)
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Table 5 1 Studies measured urinary BPA
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Based on these studies regarding the level of human BPA exposure, our
studies using a micro molar range of concentration were applicable to the
occupationally exposed populations, but probably not to the general population.
Similar to our study, the micro molar range of BPA exposures has been shown to
decrease atrial contractility in rat heart due to the alteration of NO-cGMP
signaling (Pant et al., 2011). Our studies examined only BK channels based on
the estrogen sensitive properties of BK channels, however, it is possible that
other proteins may be particularly susceptible to BPA, and may alter
cardiovascular function. Indeed, recent studies indicated that exposure levels
relevant to the general population, in the nano molar range of BPA, have been
shown to alter Ca2+ handling in cardiac myocytes, promoting arrhythmic events in
rodent hearts (Yan et al., 2011; Belcher et al., 2012). In order to address the link
between BPA exposure and cardiovascular events, further investigation is
required to answer the molecular mechanisms of BPA's effect.
Whether these BPA-induced changes in vascular BK channel function and
expression directly link to the association of BPA exposure and cardiovascular
diseases are currently unclear, our data are the first evidence to describe that
BPA modulates vascular BK channel function and expression via genomic and
non-genomic mechanisms. Further studies are needed to determine if BPA
affects other ion channels that have roles in regulating vascular function.

Future directions:
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Multiple aspects regarding the mechanism of action for BPA toxicology will
be opened to scientists in this field. First, it would be interesting to determine
whether there is a critical time or point of exposure that is associated with the
development of cardiovascular disease. Does prenatal exposure eventually lead
to cardiovascular disease in later life? How much exposure and over what time
period is required to see the development of cardiovascular disease? Does in
vivo exposure to BPA reduce BK channel expression in VSMC and alter vascular
reactivity? Second, is it possible that BPA modulates the function and expression
of other ion channels? Since steroid hormones alter Ca2+ channel expression
and function (Er et al., 2007; Ullrich et al., 2007; Sarkar et al., 2008) it will be
interesting to determine whether BPA possesses similar properties. Lastly, are
there population-specific effects of BPA? Are females more susceptible to BPAassociated disease due to the importance of estrogen signaling? Do endogenous
estrogen levels influence the toxicological effects of BPA? Additionally, since
BPA is lipophilic and accumulated in adipose tissue, (Fernandez et al., 2007a), is
the obese population affected by a higher level of BPA? These interesting
studies will require an initial characterization and a certain level of understanding
of BPA’s interaction with other molecules. Our study provided novel evidence
that BPA modulates vascular BK channel via a non-genomic and genomic
mechanisms.
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